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To those who are closest to my heart; 
To my lovely family and dearest friends 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Nothing in life is to be feared, it is only to be understood.  
Now is the time to understand more, so that we may fear less.  
/Marie Curie* 
 
 
 
* Marie Curie (1867 – 1934), Scientist and the first woman to be awarded a Nobel Prize (1903, in 
Physics). She was also the first person ever to get the award a second time (1911, in Chemistry).  
 
 
ABSTRACT 
Particles in urban environments have for a long time been associated with different 
health problems and diseases, such as worsening of asthma and chronic obstructive 
pulmonary disease as well as cancer and cardiovascular diseases. In addition, metal 
containing particles present in occupational settings and industries, particularly 
particles produced during welding, have been linked to several adverse health effects. 
In recent years it has also become obvious that humans get exposed to metal containing 
particles in subway systems although possible health effects of such exposure is 
unknown. Furthermore, engineered nanoparticles (often containing metals) are 
increasingly being used within various applications including consumer products, thus 
constituting a risk for human exposure. In all, this means that the exposure to metal 
containing particles is present in society and may increase in the future due to the 
increased use of nanoparticles in various products. 
 
There is thus today a great need for more knowledge concerning toxicity of these 
particles. The main aim of this thesis was to investigate the toxicity and underlying 
biological mechanisms following exposure to different metal containing micro- and 
nanoparticles from an inhalation perspective.  
 
In studies I-IV (paper I-IV), the toxicity and underlying mechanisms were investigated 
for a wide range of metal and metal oxide containing micro- and nanoparticles 
following exposure of cultured human lung cells (A549). In particular, the importance 
of material composition, size and ion release for induction of toxicity in terms of 
cytotoxicity, DNA damage, oxidative DNA damage, mitochondrial depolarisation, 
generation of intracellular ROS and haemolysis of red blood cells was explored. In 
general, there was a high variation in the toxic potential of the investigated particles and 
the high and size-dependent toxicity of CuO was especially highlighted in study I-II. 
One suggested reason for this is the release of toxic ions inside cells, facilitated by a 
Trojan horse like mechanism where the particles transport the ions in to the cell. The 
investigations of industrially relevant iron and chromium based particles revealed that 
ion release from these particles, in an acidic and complexing fluid, were dependent on 
particle size and most likely the surface oxide of the particles. Further, investigations of 
stainless steel (316L) in several other artificial biological fluids, with neutral and 
weakly alkaline pH, revealed that the ion release was only increased in the acidic and 
complexing fluid. The toxicity of the iron and chromium based microparticles was in 
general low but increased DNA damage potential of 316L and NiO nanoparticles was 
observed, and the latter was also confirmed in study III. 
 
In study III (paper III), several metal containing particles were observed to have an 
oxidative capacity. Despite this, no considerable oxidative DNA damage was detected 
using the FPG comet assay. The results suggest that this may be due to interference of 
some of the nanoparticles with the FPG enzyme that is supposed to find the oxidative 
damage within the assay. Ag nanoparticles particularly inhibited the enzyme, mainly 
due to Ag ions.     
 
In study V (paper V), immunological effects in healthy humans were studied during 24 
hours after a 2 hour exposure to the PM rich environment of a subway station. The 
results indicated a small, but transient, direct inflammatory response seen as a decrease 
in the level of lymphocytes in blood as well as small changes in the lymphocyte 
subpopulation in the end of the follow-up time. In addition, an increase in DNA 
damage in mononuclear cells of the blood was detected in some of the subjects.   
 
In conclusion, the results from these studies indicate that the chemical composition of 
metal containing particles is crucial for the toxicity of the tested particles. This thesis 
especially highlights toxic effects of CuO and NiO nanoparticles. Release of ions from 
particles may be one important factor for toxicity and this thesis shows that the release 
of metals ions from stainless steel particles increased in acidic pH. Additionally, 
interference of nanoparticles and toxicity assays may be important to consider and this 
thesis highlights possible interactions with FPG in the comet assay especially with Ag 
nanoparticles. Exposure to the air at a subway station, rich in metal containing particles, 
did not cause any large acute toxic effects in humans. Still, some parameters indicated 
that the immune system reacted to the exposure.   
LIST OF PUBLICATIONS 
Surname changed from Gustafsson to Kain in 2010.  
* These authors contributed equally to this work. 
 
I.  Hanna L. Karlsson, Pontus Cronholm, Johanna Gustafsson and Lennart 
Möller. Copper oxide nanoparticles are highly toxic: A comparison between 
metal oxide nanoparticles and carbon nanotubes. Chemical Research in 
Toxicology, 2008, 21(9), 1726-1732. 
 
II.  Hanna L. Karlsson*, Johanna Gustafsson*, Pontus Cronholm and Lennart 
Möller. Size-dependent toxicity of metal oxide particles – A comparison 
between nano- and micrometer size. Toxicology Letters, 2009, 188(2), 112-
118. 
 
III.  Johanna Kain, Hanna L. Karlsson and Lennart Möller. DNA damage induced 
by micro- and nanoparticles – interaction with FPG influences the detection of 
DNA oxidation in the comet assay. Mutagenesis, 2012, 27(4), 491-500. 
 
IV.  Yolanda Hedberg, Johanna Gustafsson, Hanna L. Karlsson, Lennart Möller 
and Inger Odnevall Wallinder. Bioaccessibility, bioavailability and toxicity of 
commercially relevant iron- and chromium-based particles: in vitro studies 
with an inhalation perspective. Particle and Fibre Toxicology, 2010, 7:23.  
 
V.  Johanna Kain, Anna Klepczynska-Nyström, Hanna L. Karlsson, Britt-Marie 
Larsson, Benita Engvall, Anders Lundin, Anders Eklund, Johan Grunewald, 
Magnus Svartengren and Lennart Möller. Inflammation and DNA damage in 
healthy humans after subway air exposure – a time series study.  
Submitted in 2013. 
 
 
 
Additional publications not included in the thesis: 
 
1. Roger W. L. Godschalk, Clara Ersson, Maciej Stepnik, Magdalena Ferlińska, 
Jadwiga Palus, João Paulo Teixeira, Solange Costa, George D. D. Jones, Jennifer 
A. Higgins, Johanna Kain, Lennart Möller, Lykke Forchhammer, Steffen Loft, 
Yolanda Lorenzo, Andrew R. Collins, Frederik-Jan van Schooten, Blanca Laffon, 
Vanessa Valdiglesias, Marcus Cooke, Vilas Mistry, Mahsa Karbaschi, David H. 
Phillips, Osman Sozeri, Michael N. Routledge, Kirsty Nelson-Smith, Patrizia 
Riso, Marisa Porrini, Adela López de Cerain, Amaya Azqueta, Giuseppe Matullo, 
Alessandra Allione and Peter Møller. Comparison of DNA damage levels in 
mononuclear cells from humans in five European countries. Submitted in 2013 
 
2. Johan Olsson, Johanna Kain, Clara Ersson, Birgitta Sundberg, Arvo Hänni, Samar 
Basu, Bengt Vessby, Mark Stavro, Ina Schoppe and Lennart Möller. Dark 
chocolate consumption does not influence blood pressure, oxidative damage, 
inflammation, body weight or blood lipids. Manuscript under preparation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PREFA
 
When I 
nanotoxico
nanotoxico
in the size
used in di
potential i
first studie
and comp
have realis
field that t
our initial 
than 400 ti
     Particle
years, and
necessity 
characteris
particles w
research th
which me
addressed 
     The inc
in the soc
(outside th
The Swed
National a
has put my
insight. 
 
              
 
PS. If your
thesis, or th
CE 
was intro
logy. The 
logy had a
 of nanome
fferent con
mpact on o
s I was inv
ared, and s
ed the exte
o a large d
discoveries
mes in othe
 toxicology
 collabora
today. Thi
ation of p
e are inv
at has giv
thods that 
within pape
reased amo
iety. Along
e lab) with 
ish Governm
ction plan 
 research in
                
 time is lim
e Swedish su
duced to 
year was 2
ctually been
tres (comp
sumer prod
ur health. It
olved in, th
ome funda
nt to which
egree was 
 (paper I an
r scientific 
 research h
tions betw
s has prov
articles and
estigating!
en us new 
are most su
r III in the p
unt of kno
side my Ph
an investiga
ent Offici
for the use 
 a new con
The focu
nanoparti
intentiona
produced
system of
toxicolog
and mor
mechanis
 
With that
journey. I
 
   /Johann
ited, I recom
mmary at th
the researc
007 and th
 introduced
arable to th
ucts, and th
 was in tha
e toxicity o
mental que
 these studi
undiscovere
d II) have,
articles, wh
as become
een resear
en to be 
 it is a de
A lot of r
knowledge
itable for 
resent thes
wledge and
D-studies
tion for the
al Report S
and handlin
text and ha
s of my
cles and
lly produce
 particles 
 Stockholm
y, in which
e complex
ms in cultiv
 said, it is 
 wish you a
a Kain, St
mend you t
e end. 
h of parti
e research 
 only a few
e size of v
erefore qu
t context th
f different 
stions wer
es have con
d at the tim
at the time 
ich I find am
 more and 
chers with 
especially
mand toda
esearch ha
, but also n
testing toxi
is.  
 questions h
I have had
 Swedish G
OU2012:89
g of nanom
s provided 
 thesis is
particles in
d nanopart
from the s
. This thes
 the approa
 going f
ated cells to
time to turn
 pleasant ex
ockholm Aug
o take a sho
cles, it w
field was b
 years earli
iruses) wer
estions wer
at I started
nanoparticl
e answered
tribution to
e. The tw
of this writ
azing and
more advan
different 
important 
y that we 
s been per
ew questio
city of nan
as caused 
 the great o
overnment 
, with the p
aterials in 
me with a l
 metal c
 microme
icles as we
teel industr
is is a jour
ch of the s
rom studie
 health effe
 page and 
perience! 
ust 2013 
rtcut and re
as to the 
rand new, 
er, in 2004. 
e increasing
e raised ab
 my researc
es were inv
. Retrospec
 the researc
o articles p
ing been ci
 it makes m
ced during
background
when it c
know exac
formed sin
ns. One ex
oparticles, 
a demand f
pportunity
regarding t
urpose to 
Sweden. T
ot of experi
ontaining 
tre size, i
ll as uninte
y and the
ney through
tudies beco
s of effe
cts in huma
to start this
ad the abstra
field of 
the term 
Particles 
ly being 
out their 
h. In the 
estigated 
tively, I 
h field, a 
resenting 
ted more 
e proud!  
 the past 
s are a 
omes to 
tly what 
ce 2004, 
ample is 
an issue 
or action 
 to work 
his issue; 
present a 
his work 
ence and 
particles; 
ncluding 
ntionally 
 subway 
 particle 
me more 
cts and 
ns.  
 exciting 
ct of this 
TABLE OF CONTENTS 
 
1  Introduction ................................................................................................................ 1 
1.1  Air pollution and health effects – a historical overview up until today .......... 1 
1.2  Particles ............................................................................................................. 3 
1.2.1  Definitions and origin ...................................................................... 3 
1.2.2  Limit values ...................................................................................... 4 
1.3  Metal containing particles and health effects .................................................. 4 
1.3.1  Occupational exposure, industrial work and welding ..................... 5 
1.3.2  Nanoparticles .................................................................................... 7 
1.3.3  The subway..................................................................................... 11 
1.4  Lung exposure and mechanisms .................................................................... 12 
1.4.1  Lung exposure – deposition, dose, clearance and translocation ... 13 
1.4.2  Mechanisms of toxicity – oxidative stress, inflammation and DNA 
damage…. ................................................................................................... 17 
1.5  Burning questions ........................................................................................... 23 
 
2  Research aim ............................................................................................................. 25 
2.1  General aim ..................................................................................................... 25 
2.2  Specific aims ................................................................................................... 25 
2.2.1  The thesis will answer the following questions ............................ 25 
 
3  General study approach and analytical methods ................................................. 26 
3.1  General study approach .................................................................................. 26 
3.1.1  Exposure of cells, in vitro .............................................................. 26 
3.1.2  Chemical studies, in vitro............................................................... 27 
3.1.3  Studies of human exposure, in vivo ............................................... 28 
3.2  Particle characterisation and air monitoring .................................................. 29 
3.2.1  Particle size and morphology ......................................................... 29 
3.2.2  Surface area and charge ................................................................. 31 
3.2.3  Air monitoring ................................................................................ 32 
3.3  Toxicity testing ............................................................................................... 33 
3.3.1  Particle exposure in vitro - dose, time and sample preparation .... 33 
3.3.2  Cell viability - cytotoxicity ............................................................ 34 
3.3.3  Intracellular ROS ........................................................................... 35 
3.3.4  Damage of DNA ............................................................................ 35 
3.3.5  DNA repair – hOGG1 activity ....................................................... 37 
3.3.6  Mitochondrial depolarisation ......................................................... 38 
3.3.7  Haemolysis ..................................................................................... 39 
3.3.8  Inflammation .................................................................................. 39 
3.3.9  Other human health markers – lung permeability, lung function, 
self graded symptoms ................................................................................. 40 
3.3.10  Interference of particles with toxicity assays ................................ 41 
4  Results and discussion – particle toxicity .............................................................. 43 
4.1  The role of chemical composition ................................................................. 43 
4.2  The role of size, surface area, charge and metal ion release ........................ 48 
4.3  Interaction with toxicity testing and other methodological considerations for 
the comet assay ....................................................................................................... 54 
4.3.1  Interference of particles with the comet assay .............................. 54 
4.3.2  Comparison of FPG and hOOG1 for detection of oxidative DNA 
damage… ................................................................................................... 56 
4.4  Human exposure to subway particles and health effects .............................. 58 
 
5  Summary and conclusions ...................................................................................... 62 
5.1  Concluding remarks ....................................................................................... 62 
5.2  Future remarks ............................................................................................... 64 
 
6  Svensk populärvetenskaplig sammanfattning ..................................................... 65 
 
7  Acknowledgements – Tack! .................................................................................... 67 
 
8  References ................................................................................................................. 69 
   
LIST OF ABBREVIATIONS 
A 
ALF 
ALS 
ASW 
ATF 
AP 
BAL  
BER 
BET 
BSA 
C 
CC16 
COPD 
CRP 
DCF 
DCFH-DA 
Adenine 
Artificial lysosomal fluid 
Alkali labile sites 
Artificial sweat 
Artificial tear fluid 
Apurinic or apyrimidinic 
Bronchoalveolar lavage 
Base excision repair 
Brunauer Emmet Teller 
Bovine serum albumin 
Cytosine 
Clara cell protein 16 
Chronic obstructive pulmonary disease 
C-reactive protein 
Dichlorofluorescin 
2’,7’ – dichlorofluorescin diacetate 
DLS 
DMEM 
Dynamic light scattering
Dulbeccos minimal essential medium 
DNA Deoxyribonucleic acid
DSB 
EC 
Double strand break 
Electrochemical 
ECHA 
ECNIS 
ECVAG 
ELISA 
ESCODD 
EtBr 
European Chemical Agency
Environmental Cancer risk, Nutrition and Individual Susceptibility 
European Comet assay Validation Group 
Enzyme-linked immunosorbent assay 
European Standards Committee on Oxidative DNA Damage 
Ethidium bromide 
EU 
FACS 
FapyA 
FapyG 
FBS 
European Union 
Fluorescence-activated cell sorting 
Fapy-adenine 
Fapy-guanine 
Foetal bovine serum 
FEV1 
FPG 
Forced expiratory volume during the first second
Formamidopyrimidine DNA glycosylase 
FVC 
G 
GC 
Forced vital capacity 
Guanine 
Guanine-Cytosine base pair 
GMB 
HPLC 
Gamble´s solution
High performance liquid chromatography 
IL 
ISO 
LALLS 
LDH 
μm 
Interleukin 
International Organization for Standardization 
Low angle laser light scattering 
Lactate dehydrogenase 
Micrometre, 10-6 x metre, 0.000 001 metre 
MTT 
NER 
nm 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
Nuclear excision repair 
Nanometre, 10-9 x metre, 0.000 000 001 metre 
hOGG1 
PBMC 
PBS 
PEF 
PM 
Human oxoguanine glycosylase
Peripheral blood mononuclear cells 
Phosphate buffered saline 
Peak expiratory flow 
Particulate matter 
PM10 Particulate matter, diameter <10 μm
PM2.5 Particulate matter, diameter <5 μm
PMN 
Ro 
ROS 
Polymorphonuclear neutrophils
A photosensitiser 
Reactive oxygen species 
SCENIHR 
SEM 
SSB 
Scientific Committee on Emerging & Newly Identified Health Risks
Scanning electron microscopy 
Single strand breaks 
Smog Smoke and fog
T 
TA 
TEM 
TMRE 
UV 
VAS 
VC 
WHO 
Thymine 
Thymine-Adenine base pair 
Transmission electron microscopy 
Tetramethylrhodamine ethyl ester 
Ultraviolet 
Visual analogue scale 
Vital capacity 
World Health Organization 
8-OxodG 8-oxo-7,8-dihydro-2’-deoxyguanosine
 
 
 
 
 
 
 
 
 
 
  1
1 INTRODUCTION 
 
Exposure to air pollution, containing particles, chemicals and biological material, is for 
many of us known to be a health hazard. This has, however, not always been the case 
and today’s knowledge of the link between exposure to air pollution and ill health has 
evolved during centuries. To be able to understand the research field of particle 
toxicology, which is the topic of the thesis you hold in your hands, there is a need to 
start from the beginning and to understand the research of air pollution and what has 
been achieved within it, particularly during the last decades. Much of what is known 
about particle toxicology today derives from knowledge of air pollution. 
 
 
1.1 AIR POLLUTION AND HEALTH EFFECTS – A HISTORICAL 
OVERVIEW UP UNTIL TODAY 
Exactly when the first connection was made between air pollution and ill health is not 
possible to know. However, work in dusty mines and health effects seen in workers, 
were described many years ago by Hippocrates who lived between 470-360 BC. When 
the printing press was invented in 1450, Georgius Agricola, later referred to as the 
father of mineralogy and occupational hygiene, printed his famous book De re 
metallica (the nature of minerals) 1 and for the first time lung disease and work in dusty 
mines were linked to each other. A direct connection between the exposure of dust and 
health effects was, however, not made at this point. His second book De Animantibus 
Subterraneis, about the demons of mines, demonstrated the various ideas circulating 
during this time period concerning “exposures” in this work environment. After the 
book by Agricola, the knowledge of diseases in workers exposed to air pollution, 
particularly in mines, increased. Nonetheless, it was not until the industrial revolution 
(1760-1820) that legislators started to get interested in the matter and it took until the 
early 20th century until something was done to protect workers from danger in their 
work environments. Knowledge of health effects from exposure of air pollution from 
this time period is mainly based on exposure to quartz (crystalline silica), coal and 
asbestos, together responsible for the greatest amount of lung disease in history so far 2. 
 
Up until this point, health effects from air pollutants had been associated with work 
environments. In the mid 20th century, however, intense industrial air pollution led to 
some incidents causing exposure to the population. One of the most well documented 
incidences is often referred to as the “London smog”, which occurred in 1952. Cold, 
stagnant weather conditions and high levels of air pollution caused by coal heating 
induced high levels of air pollutants (as high as 1620 μg/m3) for several days. Analysis 
of the death statistics have shown that the death rate was increased not only during the 
episode, but for several month after the episode and that the total numbers of deaths 
were around 12 000 3. The London smog and additional incidents at that time lead to 
the first public action to reduce air pollution: The British Clean Air Act of 1956. It was 
the first effort in the industrialised world to reduce emissions from industries and 
domestic heating. This and further legislations made in the Western society has to a 
  2 
great extent eliminated these dense winter smogs that caused increased mortality in 
numbers of thousands.  
 
The source of pollution gradually changed with the introduction of the automobile in 
the beginning of the 20th century, from the coal burning to pollution from combustion 
in engines of cars. The increased awareness of the influence of air pollution on health 
led to large epidemiological studies in the 1960s and 70s 2. These were large population 
studies that established a correlation between death rates and concentrations of particles 
and sulphur dioxide in the air. These studies showed short-term relationships between 
these variables, as well as long-term effects. One of the most famous studies is the so 
called Six cities study 4 in which six cities in US were compared, and a correlation of 
death rates with increased PM levels was shown. This study and other recently 
conducted studies have revealed negative health effects at quite modest exposure levels.  
 
Until the beginning of the 1990s, studies had primarily focused on respiratory effects of 
exposure to air pollution. A clear link between exposure and worsening of allergic and 
inflammatory conditions of the lung, such as asthma and chronic obstructive pulmonary 
disease (COPD) has additionally been established since then 5. Several studies have 
also indicated an association between exposure to traffic related particles and 
cardiovascular diseases in recent years 6. Since the prevalence of cardiovascular 
diseases is increasing in the world the role of air pollution in regard to this matter is 
highly important to investigate. A recent study looking at cancer risk among 300 000 
European citizen and the link to ambient particles, has revealed that particulate matter 
(PM) contributes to the cancer incidence and even at levels below the PM limit values 
set by EU 7. The World Health Organization (WHO) estimates that over 1.3 million 
deaths of today can be endorsed to health effects caused by ambient air pollution 8.  
 
In the 1990s, engineered materials in nanometre size started to become increasingly 
important for technical applications. This is an industry, which yet today is highly 
important and the new technology has opened up for a large amount of new beneficial 
applications. The materials used are often in the form of particles (nanoparticles), 
raising concern of their impact on human health and nature. The term nanotoxicology, 
established in 2004 9, has become a field of science relevant to both workplaces, 
general environments and the consumer safety 10. 
 
An interesting observation made by K. Donaldson and A. Seaton 2 is that the 
introduction of engineered nanoparticles has changed the way that research deals with 
particle toxicology. Previously, adverse health effects were reported prior to 
investigating the toxicity and potential mechanisms of particle exposure. Today, a large 
amount of research of particles aims to understand a potential hazard of particle 
exposure before health effects have been observed. This approach has for some decades 
led to investigations of work environments, including industries and production sites, as 
well as other potential places where exposure to air pollution is suspected, and where 
there might be a risk for human health. One such area is the exposure of unintentionally 
produced metal containing particles, which will be discussed later on in this thesis (in 
the studies of metal industries and in the subway system).   
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1.2 PARTICLES 
1.2.1 Definitions and origin 
Air normally consists of a range of different atmospheric gases, water vapour and a 
background level of particles. The composition of air is essential for life and when the 
composition is disrupted by e.g. human activities or natural causes, the amount of any 
of these components may be altered. If the levels of gases or particles are increased the 
air becomes polluted. The word air pollution includes components originating from 
many different sources, some related to human activities (e.g. car engines and fires) and 
some to natural sources (e.g. sandstorms and volcanoes).  
 
The term aerosol is an expression used to describe the subset of air pollution containing 
particles. The definition includes both liquid and solid particles that are suspended in a 
gas, which most often is air 11. Particles or particulate matter (PM) less than 100 μm in 
size can often become airborne and a wide range of objects may be considered as 
particles; naturally occurring particles such as snow, sand and sea-salt, biological 
particles including pollen, bacteria and viruses as well as man-made particles of e.g. 
smoke and dust in work and home environment produced either intentionally or 
unintentionally 12.  
 
Particles are often defined by their size and the terms coarse (>2.5 μm), fine (<2.5 μm) 
and ultrafine particles (<100 nm) are often used for ambient PM. Coarse particles are 
often mechanically produced e.g. by wear of a material. They are relatively heavy and 
have a short lifetime, travelling only a small distance in air before they fall to the 
ground. Ultrafine particles are often formed from gas phase components e.g. during 
fossil fuel combustion, from evaporation of metals during for example welding or from 
intentional production in factories for use in e.g. technical products. Their lifetime is 
also short; they are in air for only minutes to hours before they deposit onto surfaces or 
combine into lager particles. Fine particles can be formed both by mechanical wear and 
by growth of ultrafine particles via coagulation (combination of small particles into a 
larger one) or condensation (a gas molecule condense on a solid particle). Fine particles 
seldom get larger than a couple of micrometres, which make their lifetime and travel 
distance in air much greater than coarse and ultrafine particles. They can stay in the 
atmosphere for days up to weeks and travel more than 100 km with wind before 
removed from the atmosphere, often by rainy weather 12. 
 
Nowadays, there is a great intentional production of particles below 100 nm for use in 
e.g. technical and medical applications. This is due to the unique properties particles 
may have in this small size range. The term engineered nanoparticle is most often used 
for these particles. However, the term nanoparticle is sometimes used in the literature 
for ambient ultrafine particles as well. Throughout this thesis, the term nanoparticles 
only refer to the engineered ones.  
 
Particle concentration in air is often measured by two fractions referred to as PM10 
(mass concentration of particles <10 μm) and PM2.5 (mass concentration of particles 
<2.5 μm). Limit values exist for both PM10 and PM2.5 in ambient air. 
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1.2.2 Limit values 
The European Commission has decided on air quality standards, limit values, for 
PM10 and PM2.5 in ambient air 13. For PM10 the limit value of 50 μg/m3, as a mean 
value over 24 hours, is not allowed to be exceeded more than 35 days/year. The mean 
value over one year should not be over 40 μg/m3. For PM2.5 a so called target value of 
25 μg/m3 has been set, which member states should try not to exceed as a mean value 
over one year. This target value will become a set limit value that enters into force in 
2015. Since PM10 and PM2.5 are based on mass concentration of particles, the 
measured values are mostly affected by the larger particles in the sample. Ultrafine 
particles often dominate the number concentration of particles in ambient air, but 
represent only a small fraction of the total mass concentration. Hence PM10 and PM2.5 
mainly give information about the amount of particles in micrometre size.  
 
Occupational environments do also have limit values 14. Some examples of exposure 
limit values that should not be exceeded during a workday (8 h) are 3.5 mg/m3 for iron 
oxide, 0.2 mg/m3 for copper and 0.1 mg/m3 for manganese (respirable dust). Silver 
should not be above 0.1 mg/m3 and chromium should not be over 0.5 mg/m3 (total 
dust). For chromium VI (the ionic form) the limit value is 5 μg/m3. 
 
No specific limit values exist for nanoparticles. If nanoparticles are present in ambient 
air, the standards for PM should be followed. If present in a workplace, occupational 
limit values are valid and the particles chemical composition (e.g. which metal it 
consists of) then decides which limit value that should be followed.  
 
 
1.3 METAL CONTAINING PARTICLES AND HEALTH EFFECTS 
The focus of this thesis is metal containing particles, both unintentionally and 
intentionally produced. Metal containing particles can be found in many different 
environments, such as occupational settings where particles can originate from welding 
or manufacturing work of metals. During recent years a new potential exposure of 
metal containing particles has arisen from the intentionally produced particles, present 
as nanoparticles, e.g. in consumer products. These particles may not only be a risk 
during production but may also pose a risk for consumers, as well as during disposal of 
these products. Another milieu studied in this thesis is the subway system, and the 
exposure to metal containing particles that may take place there. Particles are produced 
unintentionally in this environment and both people working in the subway system as 
well as the public, often travelling on a daily basis with the subway may be exposed. 
 
The following text will shed light on metal containing particles relevant for the present 
thesis. 
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1.3.1 Occupational exposure, industrial work and welding  
Steel industries 
During work in industrial environments, release of metal containing particles is a likely 
event during cutting, milling and melting of metals. Since workers often work close to 
the source generating particles, the occupational exposure may be high. In a study by 
Elihn and Berg 15, the characteristics of airborne particles were measured in seven 
Swedish industrial plants where mainly iron based material was processed. These 
measurements show that the highest concentrations of PM10 and PM1 (particles < 1 
μm) were present during laser cutting and welding of steel, which are processes 
generating heat, while colder processes generated lower levels. Further studies 
investigated effects of inflammation in the workers at these industries. The results 
showed increased levels of interleukin-6 (IL-6), by 52% after the first day of a work 
shift, where after an adaptation seemed to occur and the levels decreased 16. C-reactive 
protein (CRP) was also increased, by 17% after the second day into a work shift, which 
may indicate an increased risk of coronary heart disease for these workers. In other 
studies, biological samples such as hair, blood and urine, from steel mill workers with 
long-term exposure to steel, have shown elevated levels of arsenic (As), cobalt (Co), 
manganese (Mn) and copper (Cu) 17. Additionally, studies of health effects in workers 
of a Swedish copper smelter have shown increased respiratory problems linked to the 
corrosive gases and dust at the workplace, as well as excess mortality when compared 
to the general Swedish population 18.  
 
The knowledge of potential respiratory effects from exposure to iron and chromium 
based particles (ferrochromium alloys) such as stainless steel, investigated in this thesis, 
is limited. Studies of workers, exposed to low levels of particles during stainless steel 
production, have however shown such exposure to cause small clinical effects in 
terms of nasal symptoms and disease 19. Increased lung accumulation of particles in 
workers at specific positions of the stainless steel plants have also been shown 20. 
Assumptions from toxicological findings relevant for individual constituents of 
stainless steel, such as chromium (Cr) are often made trying to understand the toxicity 
of stainless steel. Hexavalent chromium (Cr(VI)) is a known carcinogen when inhaled 
21, but there is inadequate evidence for carcinogenicity of trivalent chromium (Cr(III)) 
22. In a cohort study of 4800 workers producing stainless steel, no indication was 
found regarding increased mortality due to lung cancer 23. However, long term daily 
exposures to low levels of dust and fumes containing Cr(III) have been shown to 
generate enhanced production of phlegm in the respiratory tract, shortness of breath 
and breathlessness on exertion 24.  
 
Many studies regarding the impact on health from occupational exposure to metals, are 
however, studies conducted on welders, which is discussed in the following section.  
 
Welding 
Welding is a common manufacturing tool used for joining pieces of metal together by 
heating. In a report conducted by the Swedish Work Environment Authority in 2013 25, 
it was estimated that 20 000-25 000 persons work as full-time welders in Sweden. In 
addition, approximately 250 000 perform welding as one part of their job. Welding is, 
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for example, a common procedure used in the work of auto mechanics. In industrialised 
countries, one percent of the working population are estimated to work as welders 25. 
 
During welding, fumes and particles are released and the heat that is produced causes 
the fume to rise in a column from the welding source. The materials found in the 
welding fume may originate from the electrode of the welding device, the so called 
shielding gases, from the base metals that are joined or from paint and surface coatings 
of the metals. Vaporised metals that are produced react with air and metal oxides are 
formed. When the vapour condenses, particles are produced. The chemical properties 
of the particles can be rather complex since welding material often consists of metal 
alloys (often steel), containing different amounts of for example iron, manganese, 
silica, chromium, nickel, zinc or copper. The particle concentration in the fume column 
formed during welding can be high, as much as 1000 times higher than in the air just a 
small distance away 25. The particles produced are often in a size range of 5 - 40 nm.  
They do, however, tend to aggregate and form chains of particles with a size of 0.1-1 
μm. This is mainly due to the heat formed during the welding procedure, which 
increases the movement of the particles and hence the probability of collision, causing 
formation of larger particles 26. Welding fume not only consists of particles, but also 
toxic gases such as carbon monoxide (CO), ozone (O3) and nitrogen oxides (NOx) in 
evaluated levels.  
 
The current limit value for total dust concentration in the breathing zone during a 8 h 
workday is 5 mg/m3 25. Studies conducted in the 1970’s of 500 welding workplaces 
showed that the levels often exceeded the limit value. When a similar evaluation was 
performed in 1994, the levels were lower and the limit value was not exceeded in the 
majority of the sites 25. Nonetheless, during some types of welding the number of 
particles in nanometre size can be very high even though the limit value is not 
exceeded. Threshold values for certain components of stain less steel are, however, 
much lower than that for total fume. For example, Cr(VI) has a limit value of 5 μg/m3 
(= 0.005 mg/m3). In a study by Gavelin et al. 27 Cr(VI) levels were measured during 
welding and the limit value was reported to be exceeded regularly, even when proper 
safety equipment was being used, such as specialised ventilation. 
 
Health effects and toxicity associated with welding 
Welding is associated with numerous health effects and there are several factors during 
welding that may cause disease: gases produced, ultraviolet (UV) light exposure, the 
heat of the fumes, particle exposure etc. Health problems for welders are often also 
linked to the heavy physical work they perform, as well as to other factors, such as 
noise and other more general exposures in the working environment. Nevertheless, 
particles and gases are considered to be the most harmful components of exposures 
during welding 26. It is also possible that workers smoke, a fact that cannot be neglected 
when investigating health effects. It may contribute to the effects seen in welders, but it 
may also be that smoking and welding act synergistically when introducing health 
effects, as suggested by Mur et al. in the case of bronchitis 28. 
 
Several health effects have been linked to the different metals present in the particles 
that are released during welding. Welding of stainless steel containing chromium is 
associated with asthma, lung cancer and impaired sperm quality 25. Alloys of steel may 
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release chromium, both as Cr(III) and Cr(VI). Cr(VI) is toxic and classified as a human 
carcinogen (as previously discussed) and studies of welding of metals rich in Cr(IV) 
indicate a possible increase in mortality from lung cancer among exposed workers 29. 
The report by the Swedish Work Environment Authority 25 concludes that research 
indicate that welding of stainless steel can cause lung cancer as well as cancer of the 
nose. In epidemiological studies of exposure to nickel, the same cancer forms have also 
been shown to be affected 26. Nickel is classified as a human carcinogen 30 and may 
also be released from alloys during welding. Manganese is present in most welding 
fumes and effects on the nervous system have been seen from it, contributing to 
symptoms resembling Parkinson’s disease 31. In addition, chronic inflammation of the 
nose has been observed following welding of steel alloys containing manganese 
(Werner 1977). The main component of fumes generated from most welding processes 
is, however, iron oxides and exposure to these during welding has been linked to 
airway and heart disease 25. In a case-control study by Palmer et al. 32 lung 
inflammation of hospitalised welders was linked to their exposure to welding fumes 
containing iron during the past year. Lead may also be released upon welding, and is 
well known to cause damage to the nervous system, reproduction and foetus 25. Zinc, in 
the form of zinc oxide, is the main factor causing the condition metal fume fever, which 
is the most commonly described health effect from welding. Symptoms of metal fume 
fever include transient flu symptoms such as fever and muscle pain. The importance of 
other metals for this condition is, however, unclear and suggestions that vaporised 
copper might play an important role in its development remain uncertain and needs to 
be studied more thoroughly 33,34. Metal fume fever has been suggested to be associated 
with later onset of respiratory symptoms similar to asthma 35. In epidemiological 
studies associations of respiratory disease and welding have been confirmed 26. 
Respiratory effects seen in full-time welders include, for example asthma, airway 
irritation and an increased incidence of lung cancer 25. Pulmonary infections are also 
seen to be more severe, have a longer duration time and hit welders more often.  
 
Since several welding methods exist and the metals used can differ, each welding 
method may present its own potential health hazards. In addition, other factors, 
including the conditions under which the welding takes place, affect the exposure. An 
example of such a condition is whether the welding takes place outdoors or indoors. 
Which components of the welding fume that are responsible for health effects after 
exposure is difficult to elucidate since welders are exposed to a mixture of particles and 
gases. In addition, a possible impact from smoking habits and exposure to other factors 
in the work environment may also contribute.  
 
 
1.3.2 Nanoparticles 
The prefix “nano” originates from the Greek word for dwarf and refers to something 
small. A nanometre (nm) is a billionth of a metre (10-9). The small size of a nm might 
be hard to imagine. However, the thickness of this page is actually 100 000 nm (0.1 
mm).  
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Definitions 
Several international institutions and organisations have suggested different definitions 
to be used for describing nanomaterials. However, in October 2011 the European 
Commission adopted a recommendation defining the concept of a nanomaterial as 36: 
 
”A natural, incidental or manufactured material containing particles, in an unbound 
state or as an aggregate or as an agglomerate and where, for 50 % or more of the 
particles in the number size distribution, one or more external dimensions is in the 
size range 1 nm - 100 nm. In specific cases and where warranted by concerns for the 
environment, health, safety or competitiveness the number size distribution threshold 
of 50 % may be replaced by a threshold between 1 and 50 %. 
     By derogation from the above, fullerenes, graphene flakes and single wall carbon 
nanotubes with one or more external dimensions below 1 nm should be considered as 
nanomaterials” 
 
This definition is the one used for European Union (EU) legislation. Within EU, 
nanomaterials fall under the chemical legislation of REACH, which is applicable to 
the manufacture of, placing on the market of and use of substances, on their own, in 
preparations or in products. The general obligations in REACH include that 
substances manufactured at one tonne or more need registration. The European 
Chemical Agency (ECHA) receives these registrations and the purpose is to generate 
more information useful for risk assessment. Nanomaterials that fulfil the criteria for 
classification as hazardous, must in addition be classified and labelled independently 
of the amount in which the substances are manufactured or imported 36. There have 
been discussions on how REACH should be adapted for nanomaterials since the 
production in many cases does not exceed the tonnage level 37,38. Modifications of 
REACH regarding nanomaterials are currently under discussion within the European 
Commission. 
 
The recommendation by EU mentioned above is partly based on the definition set by 
The International Organization for Standardization (ISO) where three distinctions of 
nanoobjects exist: 1) Nanoparticles (with a size between 1-100 nm in three 
dimensions), 2) Nanofibres (with two dimensions in the nanoscale) and 3) Nanoplates 
(with one dimension in the nanoscale) 39 (see Figure 1). This definition of nanoparticles 
is often used and is the one used within the studies of this thesis. 
 
Figure 1. The ISO definitions of nanomaterials, nanoobjects, nanoparticles, nanofibres and 
nanoplates. Nanoscale refers to a size between 1 and 100 nm. Image reproduced from Krug 
and Wick 39 with minor modifications, with permission from John Wiley and Sons. 
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The use of nanomaterials and nanoparticles 
The global market for nanomaterials is currently estimated to be 11 million 
tonnes/year 43. Some nanomaterials have been produced and in use in large volumes for 
almost a century, such as carbon blacks used for the manufacturing of rubber and 
pigments. Silica and oxides of titanium are examples that have been in extensive use 
for almost half a century, as agents in paint and cosmetics 42. According to the 
European Commission, also aluminium oxide, barium titanate, cerium oxide, zink 
oxide, carbon nanotubes and nanofibres, as well as silver are produced in thousands 
of tonnes yearly 43. Lately, many new applications containing nanomaterial have been 
developed, e.g. consumer products such as cosmetics, sunscreens, anti-odour textiles, 
coating of self-cleaning windows and roofs, and food packaging. The amount of 
nanomaterial-containing consumer products on the market is today estimated to be over 
1000, with the most commonly used nanomaterials being silver, carbon, titanium and 
silica 44. In addition, medical and technical applications including cancer therapies, 
lithium-ion batteries for electrical cars and solar panels utilising nanomaterials also 
exist. Environmental benefits from using nanotechnology are suggested to include 
reduction of energy consumption as well as emission of green house gas emission 45,46. 
All the applications mentioned have the potential to create major technological 
breakthroughs for the society 47 and be beneficial in a lot of different sectors, such as in 
the electronic industry, the construction industry, engineering and environmental 
technology. Within EU 300 000 - 400 000 jobs is currently linked to nanotechnology 48.  
 
Human exposure - toxicity and health effects 
The same properties that make nanoparticles so attractive to use in different contexts 
are properties that potentially can cause toxicity and damage to cells. If nanoparticles 
are compared to other biological materials they are in the same size range as viruses, 
smaller than bacteria and the cellular nucleus. Hence, there is no surprise that cell 
interaction may be possible. Nanotechnology has been around for quite some time, but 
studies of the toxic potential of nanomaterial lag behind. For most manufactured 
nanoparticles there is a lack of toxicity data available, or the data is inadequate. 
Toxicity studies of particles in nanometre size have indicated that particles cause 
toxicity in lower doses than larger particles of the same material 42. However, the 
toxicity seems to differ depending on which characteristics the nanoparticles possess. 
Analysis of published data of in vitro toxicity of metal containing nanoparticles suggest 
that nanoparticles that are oxidised, reduced or dissolved are cytotoxic and genotoxic 
while stable metal containing nanoparticles indicate no significant cellular toxicity 49. 
Moreover, other properties of metal containing particles, such as the possible presence 
of transition metals that may cause the formation of reactive oxygen radicals (which 
will be discussed later on) may be particularly important for these particles. Aust et al. 
50 showed, for example, that transition metals of particles were linked to radical 
formation and subsequent release of cellular mediators important for the induction of 
respiratory symptoms. Studies of prolonged exposure of rats (of e.g. carbon black, 
titanium dioxide, iron oxides and amorphous silica) have, in addition, shown airway 
inflammation and lung tumours as a result 42. Yet, the knowledge of the effects of 
human exposure to nanoparticles is limited. However, epidemiological studies on 
ambient particles show that when the concentration of all kind of particle sizes are high 
in the atmosphere, morbidity and mortality increase 51.  
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The wide use of nanomaterials speaks for a range of different situations where exposure 
to these particles might occur. Inhalation is considered the major route of exposure, but 
ingestion and dermal exposure are also potential exposure routes. In the case of 
nanomedicine, exposure via administration directly to blood, subcutaneously or 
intramuscularly must also be considered. Nanoparticles that are incorporated into 
technical equipment might not be a risk to the consumer whereas products containing 
free particles, such as cosmetics, certainly will cause exposure. Production and waste 
handling of products or of the nanomaterial itself might pose a risk to workers. Data on 
exposure of nanomaterials at some workplaces have recently been reported 52,53. 
Nonetheless, the available data of exposure in the work environment is small relative to 
the number of jobs linked to nanomaterials. 
 
 
1.3.3 The subway 
In recent years high levels of particles have been observed in the subway (underground) 
systems of several major cities around the world, including Berlin 54, Helsinki 55, 
London 56, Los Angeles 57, Mexico city 58, New York 59, Paris 60, Rome 61, Seoul 62, 
Stockholm 63 and Tokyo 64. The monitored particle levels in these subway systems, in 
terms of PM2.5 and PM10, are reported to range from average values of 47 to 480 
μg/m3. In the subway of Stockholm, the levels of PM2.5 and PM10 was reported to be 
260 and 470 μg/m3, respectively, which was 10 and 5 times higher when compared to 
levels at a busy street close by 63. That the subway system presents particle levels 
comparable with, or above, PM levels of urban environments with heavy traffic is a 
phenomenon often observed.  
Subway particles 
Analyses of the origin and composition of particles from the subway system have 
concluded that the particles mainly originate from wearing of rails, wheels and brakes 
as well as from release from current collectors and conductor rails 64. Predominantly, 
the particles consist of iron and iron oxide. In a study of the subway of Stockholm, 
approximately 60% of the total mass of collected particles was iron 65. Manganese, 
chromium, zinc, copper, barium and silica are also often present in smaller amounts, as 
well as elements of aluminium, antimony, lead, nickel, tin and titanium, which are 
found in very small quantities 56,61,66. The presence and amounts of the different 
elements differ between subway systems and depend on the type of rails, trains etc. In a 
study of the subway station Odenplan in Stockholm, particles in nanometre size were 
shown by Midander et al. 67 to dominate in total particle number compared to coarse 
particles. The mean of nanometre particles were 12 000 particles/cm3 and particles 
larger than 250 nm in size were 190 particles/cm3 67. From the size modes measured of 
the nanometre particles it was suggested that both metal containing particles and diesel 
particles were present in the air of the station. 
Toxicity and health effects 
In contrast to the large number of studies performed on traffic related PM, less is 
known about toxicity and health effects from exposure of subway PM. However, 
subway particles collected in London have shown toxicity in vitro in terms of release of 
the pro-inflammatory marker interleukin-8 (IL-8) from human lung cells at the same 
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levels as welding fume particles when compared 56. In this study the subway particles 
also induced cell death and DNA damage. In another study of cultured human lung 
cells, subway particles were shown to be more potent to cause oxidative stress and 
DNA damage than traffic related particles, particles from wood combustion and tire-
road wear 68,69. Macrophages exposed to subway particles from the subway in Paris 
have been shown to increase the production of the inflammatory markers TNF-α and 
MIP-2 protein 70. Inflammatory responses such as increased amounts of neutrophils in 
bronchoalveolar lavage (BAL), altered epithelial permeability and increased expression 
of oxidative stress markers after particle exposure have also been observed, in exposed 
mice 70. Interestingly, the effects of subway particle exposure were more pronounced 
than those observed after diesel exposure. Studies regarding human health effects from 
subway particle exposure are scarce, but some studies have been conducted on the 
personnel of the subway. Bigert et.al 71 observed slightly increased levels of blood 
markers for cardiovascular disease and inflammation in exposed subway platform 
workers when compared to less or not exposed workers.  
 
The subway system is in many cities a highly important transport system with a large 
number of daily commuters. In Stockholm the subway accounts for approximately 45% 
of all the public transportation in the area with around 1 137 000 boardings each 
weekday 72. This means that human exposure to subway particles may occur daily, 
during long periods of the citizen’s life. In a study conducted in New York measuring 
the exposure levels of metal containing particles 73, the subway system appeared to be 
the dominant exposure environment for personal airborne exposures to iron, 
manganese and chromium when levels were compared to ambient and indoor air. The 
data suggest that the time spent in the subway system could be a primary determinant 
factor of the personal exposure to these metals for people who are not occupationally 
exposed. In another study 74 performed on taxi drivers and office workers in London, 
the exposure to manganese was studied before and after it was introduced as an 
additive in diesel. This study showed that the manganese exposure did not increase as 
a result of introduction of the additive. However, the mean exposure to manganese 
was higher among the office workers in both years compared to the taxi drivers. This 
was due to that approximately half of the office workers commuted via the 
underground railway system where airborne dust and manganese concentrations were 
measured to be 10-fold higher than in the general environment. Despite all this, 
studies addressing the question of whether exposure to particles in the subway 
environment could possess a risk to daily commuters, healthy persons or sensitive 
groups, are few and represent a knowledge gap. 
 
 
1.4 LUNG EXPOSURE AND MECHANISMS  
Fundamental for the understanding of health effects from particle inhalation is to 
comprehend the lung exposure. If there is no exposure there is no risk. To what extent, 
and where in the lungs, particles are deposited, in addition to how well the immune 
defence system of the body can clear the particles is essential. Translocation of particles 
from the site of entry to distant organs is currently also a highly discussed issue. 
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1.4.1 Lung exposure – deposition, dose, clearance and translocation 
Breathing is essential for life and thousands of litres of air pass the lungs every day. 
The human respiratory system can be divided into two general zones, the conducting 
zone (consisting of nose, pharynx, larynx, trachea, bronchi and bronchioles) with the 
functions to filter, warm, moister and conduct the air to the lungs and the respiratory 
zone where the gas exchange of oxygen and carbon dioxide takes place in the alveoli. 
The diameter of the alveoli is approximately 0.2 mm and the total surface area of the 
lungs is 140 m2 75. The lung barrier, which consists of a layer that is only two cells 
thick, is a unique construction that together with the large surface area enables effective 
uptake of oxygen to the body. The anatomy and present cells of the different regions of 
the respiratory tract differ to some extent and approximately 40 cell types are 
represented in the respiratory tract all together. A schematic illustration of the anatomy 
and the most common cells within the respiratory tract can be seen in Figure 3. 
  
 
Figure 3. The human respiratory tract. Image from Sun et al. 76. Published with permission 
from Nature Publishing Group.  
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Deposition  
When air contaminated with particles is inhaled, a certain amount of the particles will 
deposit in the respiratory tract. The size of the particle is an important determinant for 
where the deposit takes place, as illustrated by the graphs in Figure 4. If the respiratory 
tract is separated into nasopharyngeal, tracheobronchial and alveolar regions, 
nanoparticles can target all three of these regions. From these data it can also be 
concluded that even small changes in the size of nanoparticles alter the percent of the 
deposit in the different regions. Larger particles, over 1 μm, often deposit in the 
nasopharyngeal region and just a small fraction will reach deeper into the system 
reaching the tracheobronchial and alveolar regions. The particle deposition shown in 
Figure 4 is valid for nose breathing during rest and it is based on predictive 
mathematical models for single particles, not aggregates 10,77. 
 
 
Figure 4. Deposition of particles in the human respiratory tract. The image is a reproduced 
version from Oberdörster et al. 10, with permission from Environmental Health Perspective.  
 
 
Nanoparticles mainly deposit by diffusion, which is due to collision with air molecules. 
When nanoparticles carry a significant electric charge, electrostatic precipitation may 
also occur. Deposition of larger particles is mainly accomplished through other 
mechanisms, that do not occur for nanoparticles, such as impaction, gravitational 
settling and interception 10.  
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Exposure dose 
There is a natural dose limit of 106 particles/cm3 (particle number concentration) for 
which dispersed particles in a stable aerosol starts to merge into larger particles. This 
limit is not often reached for micrometre sized particles, but for nanoparticles this is 
achievable. For 20 and 100 nm sized nanoparticles, this particle number concentration 
corresponds to 4.2 μg/m3 and 525 μg/m3, respectively 78. This phenomenon is important 
to consider since the location of particle deposition may change if the original particles 
are increased in size. 
 
The airflow follows certain patterns in the respiratory tract, which means that particles 
of micrometre size in an aerosol often will not deposit evenly, but rather in higher 
concentration at certain locations 79. This is the concept often referred to as “hot spots” 
in the context of particle deposition. In a study of chromate manufacturing workers, it 
was shown that hot spots with higher content of chromium was found in bifurcations of 
the airways 80. A small fraction of epithelial cells in a hot spot can receive doses that 
are a few hundred times higher than the average dose of the total airways 81. In a review 
by Borm et al. 82, a calculation from in vitro data of cellular exposure to quartz in the 
dose 40 μg/cm2 (the cm2 refers to the cell-layer in a petri dish) was transformed to 
corresponding doses in exposure of rats. Their calculation showed that the total burden 
of particle deposition in the rat lung would be 155 mg if the particles were spread 
evenly in the whole lung with homogeneous concentration. This amount of particles 
exceeds threshold doses for inflammation and does not represent a likely exposure 
scenario. When this was recalculated with the idea of hot spots in mind, it was 
concluded that a much lower amount of particles (approx. 12 mg) needs to be inhaled 
to get the same concentration in the hot spot areas. If a rat inhales a dose of 6.2 mg/m3 
of quarts, that lung burden would be reached after 15 months (if exposed 5 days/week, 
7 h /day). This example is for quartz particles and whether the local dose will be the 
same for other particles is hard to predict since the characteristics of the particle 
influence this.  
 
The calculation experiment above illustrates a concept and indicates that doses around 
40 μg/cm2 used in vitro (a dose used in the studies within this thesis) may occur in vivo 
after a certain time of particle exposure at levels comparable to some occupational 
exposures. It is, however, highly important to point out that cells in vitro are exposed to 
this dose all at once and hence this dose can be considered to be high. The effects are 
also evaluated during a quite short time frame after exposure in vitro, compared to a rat 
that inhales it over a longer period of time, enabling the immune system to take care of 
the particles. In a review by Gangwal et al. 83 this issue, of what in vitro doses to use in 
order to reflect in vivo doses, was addressed. Gangwal et al. here suggest that 
concentrations between 30 and 400 μg/ml, often used in in vitro toxicity testing (40 and 
80 μg/ml have mostly been used in the studies of this thesis), are in fact relevant since 
these doses are comparable with that of daily exposures for 45 years of certain particles 
in occupational settings. As a response to this review, Oberdörster 84 highlights what 
was emphasised above, namely that results from years of exposure should not be 
extrapolated to dosage for in vitro testing of short-term exposure, and that 
extrapolations like these can be highly misleading.  For nanoparticles it is also 
important to consider whether the concept of hot spots, relevant for particles in 
micrometre size, is an occurring event or not. Studies have shown that deposition 
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patterns become more and more homogenous (the particles are more spread out) when 
particles decrease in size, especially below 100 nm 85. However, this highlights the 
importance to consider agglomerated nanoparticles, forming aggregates that may be 
more likely to deposit in certain hot spots. 
 
Clearance and translocation 
The respiratory tract has several defence mechanisms for catching and clearing foreign 
components, such as particles, from the inhaled air 10. Particles trapped in the nose and 
mouth are often sneezed out, coughed out or swallowed. If particles pass this first gate 
of clearance and deposit in the tracheobronchial region, the major pathway of clearance 
is by mucociliary transportation. Particles that deposit in this region will initially 
interact with the lung surfactant, which is a liquid creating a thin layer at the surface of 
the tissue. Particles will then move into the mucus layer underneath. The mucus is an 
aqueous gel containing a network of glycoproteins as well as electrolytes, serum 
proteins, immunoglobulins and lipids. The mucus moves towards the upper end of the 
tracheal tube due to the movement of the ciliated cells in the epithelium. Hence, 
particles will rather quickly be removed from the site of its deposit (around 24 hours). 
When the mucus reaches the pharyngeal region the particles and mucus will either be 
swallowed or coughed up.  
 
The ciliated cells are, however, rare in the alveoli and clearance here mainly depends 
on a slower clearance mechanism through phagocytosis by macrophages 86. 
Macrophages with internalised particles move towards the regions with ciliated cells 
for further transport to the larynx. This mechanism is initiated within a few hours after 
particle deposition, but it can take days or even years before the particles are cleared 
out 87. Nanoparticles may bypass phagocytic uptake by macrophages, which has been 
shown in several studies 77,88. In a study by Ferin et al. 89, lungs of rats were 
investigated after exposure of TiO2 and Al2O3 particles, and the result showed that 
particles of nanometre size were found in the lavage fluid (collected one day post 
exposure) to a much lesser extent than particles of micrometre size. The authors suggest 
that the reason for this is that the nanoparticles are taken up into the pulmonary tissue to 
a greater extent than particles of micrometre size. This was in fact also shown to be the 
case, as was seen when the content of these particles in lung tissue and lymphatic nodes 
were investigated in the same study. In a recently published review by Kreyling et al. 
78, pathways for particle clearance in the peripheral lungs include transportation to 
lymph nodes located close to the lung as well as possible further translocation from 
epithelial cells to the interstitium or beyond. For particles with a certain degree of 
solubility, dissolution of the particle may also be an important mechanism for clearance 
10,77.  
 
Inhalation studies of rats have shown that different kinds of nanoparticles to a high 
degree penetrate into the alveolar epithelium and underlying interstitium 78. 
Translocation across the air-blood barrier in the lung, have been shown to occur for 
gold, silver, TiO2, polystyrene and carbon nanoparticles in the size range of 5 - 100 
nm, in animal studies 77. Translocation mediated by alveolar macrophages from the 
lung to regional tracheobronchial lymph nodes has also been shown for micrometre 
particles 90. In a study by Choi et al. 91, the importance of chemical composition, shape, 
size and surface charge was evaluated in terms of particle translocation from lung to 
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lymph nodes in rats. The study showed that the majority of the tested inorganic as well 
as organic nanoparticles remained in the lung within 30 minutes after administration, 
but for particles < 34 nm there was a fast translocation from the alveolar luminal 
surface to regional lymph nodes. It was also seen that the smallest nanoparticles (<6 
nm) with a zwitterionic surface charge (a neutral particle with a positive and a negative 
electrical charge at different positions) very rapidly (in minutes) translocated to the 
lymph nodes, and 30 minutes later particles could be traced in the kidneys and in urine. 
Liver, bile and intestine showed no accumulation of the particles 91. Studies have also 
indicated that nanoparticles that penetrate into the interstitial spaces of the lungs of rats 
are phagocytised by macrophages and then transported back to the inner lining of the 
lung epithelium for further clearance 78. Translocation of nanoparticles to the brain, via 
the olfactory nerve, has been observed in rats 92,93. However, since the nose of rodents 
differ to a great extent to humans, with a higher developed nervous system in this 
region in rodents, it is difficult to extrapolate these findings to human.  
 
Studies like these have, however, raised concern of possible translocation of 
nanoparticles also in the human body. Several studies have tried to study translocation 
of nanoparticles from the lungs and there has been some indication of possible 
translocation, but there is no strong evidence for any major translocation beyond the 
lung. In a study of carbon nanoparticles it was estimated that approximately 1% of the 
exposure dose had translocated in the exposed human subjects 94.  Labelling of 
nanoparticles (for tracing of the particles within the body) with e.g. radio-isotopes, is 
often difficult and leaching of the isotope may be a problem 77. In translocation studies 
this is an issue that may contribute to false positive results if the probe is translocated 
instead of the nanoparticle. This may be one reason for the ambiguous results seen 
regarding e.g. translocation to blood and accumulation in the liver after inhalation of 
labelled carbon nanoparticles in humans 95,96. Due to ethical issues, studies on human 
exposure have also been difficult to conduct.  
 
Epidemiological studies have established that inhalation of ambient PM increases the 
risk for cardiovascular mortality and morbidity 97 and particles in the nanometre size 
are thought to contribute to cardiovascular effects more than larger particles 98. 
Several mechanisms have been suggested to be responsible for the systemic 
cardiovascular effects including activation of neurons in the lung that may change 
cardiac function and rhythm, direct systemic effects by translocated particles, and the 
release of inflammatory mediators from the lung into the circulation 99. If the amount 
of translocated particles is enough to give these effects is unsure and alveolar 
inflammation induced by particles initiating a systemic response with e.g. changed 
coagulation of the blood may be a more likely explanation. 
 
 
1.4.2 Mechanisms of toxicity – oxidative stress, inflammation and DNA 
damage 
If the air is contaminated with toxic components it can have a significant impact on 
human health through inhalation. The following section will explain some of the most 
common and studied mechanisms of toxicity from particle inhalation and in which way 
they are linked to common human diseases. The mechanisms described below are 
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selected in terms of their importance for particle toxicity, but also in terms or relevance 
for the studies performed in this thesis. It may also be stressed that the mechanisms 
described below often are linked to and affect each other. 
 
1.4.2.1 Oxidative stress  
Oxygen is one of the key components needed for human life and oxidation is therefor a 
constantly present event in our cells. Oxidation is a loss of electrons or an increase in 
oxidation state of a molecule, atom or ion. It is an important reaction for cellular 
function and oxidising agents are formed constantly during normal processes e.g. from 
energy production in the mitochondria of the cell 51. Many of the oxidising agents are 
free radicals, which are atoms or molecules having one or more unpaired electrons 100. 
Radicals are usually electrically neutral; no electrostatic interactions will be formed 
between radicals, but since a radical contains an atom with an incomplete outer electron 
shell, most radicals are unstable and reactive.  
 
Reactive oxygen species (ROS) is a collective term for oxygen radicals and non-radical 
derivatives. The term reactive is relative, where some of the species are highly reactive 
attacking everything they come close to and others are more selective 100. There are 
many different forms of ROS, for example the superoxide radical (O2•-), hydrogen 
peroxide (H2O2) and hydroxyl radicals (OH•) 51. The definition of ROS is today often 
described in the context of the expanded term reactive species including not only 
oxygen species, but also halogen, sulphur and nitrogen species 100. This term includes 
several species, and it is important to remember their own chemical properties.  
 
Cells can cope with a certain amount of ROS, owing to the many defence mechanisms 
that have evolved during evolution. Non-enzymatic scavenger and quenchers (also 
known as antioxidants), as well as enzymatic systems such as e.g. glutathione 
peroxidase and catalase are important in this defence against harmful ROS 101. These 
convert ROS to less toxic compounds 51, and an equilibrium state of ROS and defence 
are normally reached in the cell. If the balance is disturbed and an overload of reactive 
species is created, a situation called oxidative stress occurs. This term has been defined 
as:  
 
“a disturbance in the prooxidant-antioxidant balance in favour of the former, leading 
to potential damage” 102  
 
In the studies conducted in this thesis this commonly used definition of oxidative stress 
has been used. This definition is, however, not crystal clear and it has recently been 
suggested that the term redox imbalance maybe should be used instead 103.  
 
ROS can cause great damage if reacting with different components of the cells such as 
proteins, lipids and DNA 104,105. Necrosis (unprogrammed cell death) and apoptosis 
(programmed cell death) can also be induced. An often discussed concept in the context 
of oxidative stress and particles is the hierarchical oxidative stress model, describing a 
tiered process with particle generated ROS giving rise to oxidative stress, which 
promotes inflammation reactions and subsequently development of pulmonary 
diseases. This process is divided into three steps where low amounts of oxidative 
stress induces antioxidant enzymes, intermediate amounts activates redox-sensitive 
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signalling pathways (including e.g. MAP kinases and NF-κB activation) with 
subsequent changes in pro-inflammatory gene expression, and high amounts causes 
toxicity in terms of apoptosis and necrosis 106,107. ROS generated damages, at the 
cellular level, may lead to a range of different diseases, including atherosclerosis, 
autoimmune diseases, inflammation and malignant diseases. Actually, more than 100 
different diseases in humans have been suggested to have a link to oxidative stress 108. 
Especially cancer development and neurodegenerative diseases, such as Parkinson’s 
and Alzheimer’s disease, seem to have a strong connection 109. Oxidative stress is 
considered the most important mechanism explaining health effects from exposure to 
ambient PM 110 and several mechanisms have been defined by which particles can 
generate ROS. The mechanisms can roughly be divided into direct or indirect pathways 
111. Examples of direct reactions includes ROS production mediated by molecules at the 
surface of the particle (e.g. free radicals, transition metals or other chemicals) 107. 
Examples of indirect mechanisms include release of metals and organic compounds 
generating ROS, as well as activation of the immune system, releasing ROS as a 
defence mechanism. Particles in nanometre size have also been shown to target or 
disturb mitochondria 112, which, if damaged, may cause a release of ROS. A 
combination of these mechanisms is most likely to occur from particle exposure 111. 
 
When it comes to metal containing particles, the concept of soluble transition metals, 
e.g. iron, copper and chromium, is of high relevance. Transition metals can generate 
ROS by the so-called Fenton reaction or Haber-Weiss reaction 105: 
 
 
1) Fe3+ + O2•- → Fe2+ + O2 
2) Fe2+ + H2O2 → Fe3+ + •OH + OH- 
 
Net reaction: O2•- + H2O2 → O2  + •OH + OH- 
 
 
The significance of the Fenton reaction in vivo has been debated for many years 113, 
since the prevalence of free catalytic metals within the body is small under normal 
conditions due to metal-binding proteins. Nevertheless, the Fenton reaction might be of 
importance in conditions where an overload of metals occurs.  
 
Oxidative stress is, together with inflammation the main mechanisms linked to health 
effects caused by particle exposure 111. Oxidative stress is, however, not an isolated 
event, but rather an important player in other mechanisms of cellular damage, such as 
inflammation and DNA damage, both which will be discussed in the following 
sections.  
 
1.4.2.2 Inflammation  
Inflammation is a natural biological response in humans, with the purpose to protect 
against foreign pathogenic invaders including microorganisms (viruses and bacteria), 
mechanical injury, particles, pollen and chemicals. The immune defence consists of 
several types of protection. The first type of defence that the invaders often get in 
contact with is from the innate immune defence. It can be divided into four groups of 
barriers including anatomic or physical (e.g. membranes), physiological (e.g. increased 
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blood flow, degradation of materials, activation of the immune system by temperature, 
pH, lysozymes and interferon), endocytic and/or phagocytic (uptake by specialised 
cells) and inflammatory barriers (recruitment of macrophages and neutrophils, mainly) 
114. The innate immune system is nonspecific and has no memory; it will react similar 
every time it is exposed to foreign components, and it responds immediately upon 
invasion. In the respiratory tract, alveolar macrophages and polymorphonuclear 
neutrophil cells (PMNs) play important roles in the defence system. The PMNs are 
relatively short-lived phagocytic cells, which increase in number during inflammation. 
During an immune response they leave the blood and transfer to the lung. 
Macrophages, on the other hand, reside in the lung tissue. They also have the capacity 
of phagocytosis of particles and can, together with PMNs, initiate inflammatory 
responses in the lungs by initiating release of pro-inflammatory mediators such as 
cytokines (e.g. TNF-α) or chemokines (e.g. interleukins such as IL-8, IL-6 and IL-2) 
115. The mediators enable recruitment of additional cells, e.g. monocytes that will 
mature to macrophages in the lungs. ROS can also be released by macrophages, to 
defend the body against the invading pathogens 115. Many phagocytic cells, e.g 
dendritic cells, can present antigens for other immune cells which, together with 
secreted chemotactic peptides, stimulate proliferation and recruitment of T-
lymphocytes (helper T-cells and cytotoxic T-cells) from the lymphoid organs to the site 
of invasion and connect the innate response to the next line off defence; the adaptive 
immune defence. The adaptive immune defence responds slowly to pathogens at the 
first time of invasion, but effectively to re-exposure of pathogens. In the adaptive 
response (in addition to T-cells mediated destruction of pathogens), B-lymphocytes 
produce antibodies that bind specifically to antigens, using its specific memory from 
the last invasion. They mark the foreign components for further destruction of 
phagocytic cells.  
 
Most often, under normal circumstances, inflammation resolves itself and is a transient 
condition. If the inflammation gets out of control it might, however, cause severe 
diseases such as asthma and various pulmonary lung diseases 116, as well as cardiac 
infarction 104. At the cellular level, the production of ROS can cause damage to 
surrounding cells that may alter their cellular function and finally cause disease.  
 
Particles of various kind, both ambient PM and metal containing particles have shown 
inflammatory potential, as previously described. However, the inflammatory potential 
seems to differ between particles with different characteristics. In a study by Cho et al. 
117 where 15 metal/metal oxide nanoparticles were compared in their inflammatory 
effects after lung exposure of rats, this was demonstrated as a rather diverse 
inflammatory potential between the particles. In the context of this thesis, markers for 
inflammation have been evaluated in a human exposure study in the subway system 
(study V). 
 
1.4.2.3 DNA damage 
The human genome, consisting of the DNA, is the genetic construction code essential 
for cellular function and life. DNA consists of a double stranded helix, built up of 
sequences of nucleotides. A nucleotide is composed of a nucleobase, a five-carbon 
sugar (either ribose or 2-deoxyribose) and one or more phosphate groups. The 
nucleobases are: adenine (A), cytosine (C), guanine (G) and thymine (T). The 
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nucleobases of one of the backbone strands connect to the nucleobases of the other by 
base pairing of G-C and T-A. The genetic code is created by the sequence of the 
nucleobases. It is translated by the cells to specific sequences of aminoacids during the 
transcription, which creates proteins. This process is crucial for life and damage to the 
genome may cause lesions that are fatal, e.g contributing to the development of cancer. 
Cancer development is, however, complex including several steps and taking a long 
time, often many years. There are several cellular changes that have been considered to 
be needed for a cell to become a cancer cell. The cell needs to be changed so it 1) 
sustains proliferative signalling, 2) does not respond to anti-growth signals, 3) is 
resistant to cell death (apoptosis), 4) has the capability to invade tissue and metastasise, 
5) can induce angiogenesis and 6) has a limitless replication 118. In recent years, two 
more characteristics have been discovered to be important as well, 7) a possibility to 
reprogram energy metabolism and 8) the characteristics to evade immune destruction 
119. Damage to DNA, which is not repaired or taken care of in any other way (e.g. by 
apoptosis) may lead to genetic instability and alteration, i.e. mutation, which can 
contribute to changes in the characteristics of a cell. If the cell is unlucky, the mutation 
occurs in a gene important for development of any of the eight characteristics 
mentioned above and then the cell is one step closer to becoming a cancer cell.  
 
Exposure to ambient particles is associated with cancer 120 and two main mechanisms 
have been described by which particles might cause damage to DNA: primary and 
secondary genotoxicity 121. Primary genotoxicity refers to genetic damage caused by 
particles without the involvement of inflammation. Primary genotoxicity can be either 
direct or indirect. Direct, primary genotoxicity is caused by direct interaction of the 
particle with genomic DNA. This includes reactions via the particle surface, e.g. by 
ROS bound to the particle surface causing an oxidative attack, or by physical 
interaction of the particle and DNA. Direct interaction between the surface and DNA is 
only possible if the particle is close to DNA, which means that particles need to be 
taken up into the nucleus. Nanoparticles may gain direct access to DNA via transport 
into the nucleus through nuclear pores. However, it is likely that nanoparticles need to 
be no more than a few nanometres in size to be able to pass the nuclear pore complex, 
which itself is less than 8 nm in diameter 122. Particles may also, possibly, come in 
contact with DNA during mitosis when the nuclear membrane breaks down. To what 
extent nanoparticles can get into the nucleus is under debate, but studies of e.g. CuO, 
silica and polystyrene nanoparticles have shown particle lodging in the nucleus 123-125. 
For silica, Borm et al. 82 have shown that a very high dose is needed for genotoxicity to 
occur by the direct, primary mechanism. Evaluation of the cells in this study, by 
electron microscopy, demonstrated that there were no particles present in the nucleus. 
Therefore, the DNA-damaging effects of these particles was not due to penetration of 
the particles into the nucleus, thus indicating that DNA damage of the particles in fact 
was caused by an indirect mechanism 82. Indirect, primary genotoxicity refers to DNA 
damage that occurs due to enhanced production of ROS caused either directly at the 
surface of the particles or by contact of particles with e.g. mitochondria. Depletion of 
antioxidants caused by particle interaction may also increase the amount of ROS in the 
cell. Release of metals or organic species from the surface of the particle may be an 
additional source to ROS production. The ROS may reach the nucleus and damage 
DNA. Secondary genotoxicity is a consequence of inflammation, where the 
inflammatory cells (macrophages and polymorphonuclear neutrophils) produce 
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Repair of DNA lesions 
Damage to DNA is most often effectively repaired by different repair systems of the 
cell. Oxidative lesions as well as strand breaks are mainly repaired by base excision 
repair (BER), bulky adducts or bulky single strand break by nuclear excision repair 
(NER) and double strand breaks by homologous recombination or non-homologous 
end-joining. In the following text the focus will be on repair of 8-oxoguanine. 
 
BER is the major pathway for removal of damaged bases and it is performed by several 
enzymes that collaborate 100. The principal steps of the BER starts with the damaged 
base being found and cut off by a lesion specific DNA glycosylase, creating an apurinic 
or apyrimidinic (AP) site. The AP site will cause a single strand break, either created by 
the DNA glycosylase itself or by an AP endonuclease enzyme. A DNA polymerase and 
a ligase then glue the parts together and insert a correct nucleotide. The human 8-
oxoguanine DNA glycosylase (hOGG1) is the BER enzyme that removes 8-
oxoguanine 134. The bacterial version of this enzyme is called formamidopyrimidine 
DNA glycosylase (FPG) or MutM.  
 
The NER is performed by several sets of repair enzymes and it works in a similar way 
to BER; it finds the damage, cuts DNA, a DNA polymerase fills this gap and a ligase 
glues it together. However, for BER only one base is often removed while NER makes 
a cut a certain distance from the lesion and a so called oligonucleotide (a short piece of 
the DNA) is removed. NER is important for removal of UV-induced damage, but can 
also remove oxidative lesions such as 8-oxoguanine 100. 
 
The BER and NER takes place before DNA replication 100. However, mismatch repair 
is also used as a repair mechanisms for 8-oxoguanine 135, and it acts on damage post 
replication 100.  In the creation of a GC to TA transversion caused by 8-oxoguanine 
(previously described), 8-oxoguanine is base-paired to adenine in an intermediate step. 
The Mut protein hMUTYH can recognise this incorrect base-pairing, making mismatch 
repair an additional repair mechanism for 8-oxoguanine lesions 100. 
 
 
1.5 BURNING QUESTIONS 
Ambient particles are today known to cause health effects when inhaled, which raises 
concern about the impact of other types of particle exposures. The most burning 
questions of particle toxicology of today are to do with whether nanoparticles pose a 
new kind of threat to human health. There is a great need for more knowledge 
concerning the nanoparticles and nanomaterials that already are produced, already 
found on the market and already used by consumers. Is there a potential risk to human 
health and the environment from nanoparticle exposure? To be able to solve these 
questions there is a need for reliable test methods, that can be used and work for the 
testing of nanoparticles. In addition, suitable legislation and guidelines for risk 
assessment is urgently needed in order to be able to use these materials in a safe and 
responsible way. The potential risks versus the great benefits that nanotechnology may 
bring is a current dilemma. In this era of problems regarding greenhouse gases and 
global warming, can we afford to stop techniques based on nanomaterials on vague and 
ambiguous grounds if they may help in these matters? Which risks are we willing to 
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take to serve other purposes? Other applications of nanomaterial may also be important 
for the development of more “environmental friendly” products, and nanomaterials in 
medical treatment may save lives in the future. However, distinctions may have to be 
made between products and applications that aid in achieving a sustainable 
development and those that are unnecessary in society. Do we need nano-containing 
products that do not improve existing products to a great deal and where the risk of 
adverse effects for humans and the environment are greater than the positive effects of 
use?  
 
In the field of particle toxicology questions regarding what underlying mechanisms that 
cause health effects are also important. In the context of understanding the possible link 
between exposure and public health diseases such as cardiovascular diseases, this is 
crucial to investigate. It is, however, also important in order to increase the knowledge 
of new exposure scenarios from particles of materials that have not yet been studied to 
a great extent. These may include certain particles in work environments such as the 
metal industry and the subway system, both evaluated in this thesis.  
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2 RESEARCH AIM 
 
2.1 GENERAL AIM 
The overall aim of this thesis is to increase the knowledge concerning toxicity and 
underlying biological mechanisms following inhalation of metal containing particles. In 
the studies conducted, this has been investigated in vitro in lung cells after exposure to 
engineered particles (in micro- and nanometre size) as well as after exposure to 
particles from steel industries and the subway system of Stockholm. In addition, health 
effects of human exposure to subway particles have been investigated in an in vivo 
(human) study. Main indicators for toxicity and health effects have been markers for 
oxidative stress and DNA damage. Inflammation has also been investigated in the 
human study. 
 
2.2 SPECIFIC AIMS 
More specifically, the aims are to: 
- Identify the role of chemical composition and size for the toxicity of metal 
oxides. 
- Investigate metal ion release and toxicity of commercially relevant iron and 
chromium based particles. 
- Explore the ability of various metal containing particles to cause DNA damage 
and oxidative stress, and to investigate whether the particles interact with the 
method (the comet assay) used for these analyses. 
- Study health effects in humans after exposure to air pollution at a subway 
station in Stockholm. 
 
 
2.2.1 The thesis will answer the following questions 
1) How important is the chemical composition, solubility and surface reactivity for 
toxicity of metal containing particles? (Paper I, II, III) 
2) If particles have the same metal origin, is the particle size then an important 
factor for toxicity? (Paper II, III) Are nanoparticle more toxic than particles of a 
larger size? (Paper II) 
3) Can methods used for toxicity testing of chemicals, be used for particles or do 
they interact with the test method, causing false results? Is this a problem 
especially for nanoparticles and the comet assay? (Paper III) 
4) Are iron and chromium based particles from the stainless steel industry toxic? 
Can particle surface characteristics or released ions in synthetic biological 
media be predictors of toxicity towards lung cells?   (Paper IV) 
5) Does a short time exposure to metal containing subway particles cause acute 
inflammatory effects, oxidative stress or DNA damage in exposed humans? 
(Paper V) 
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3 GENERAL STUDY APPROACH AND ANALYTICAL 
METHODS 
The detailed study designs as well as methods and materials used are described in each 
separate paper (see paper I-IV).  
 
 
3.1 GENERAL STUDY APPROACH 
Responses following exposure to particles are complex, when seen to the human as a 
whole since several cell types and mechanisms are involved when particles interact 
with the human body. The use of different exposure models is therefore common 
practice when testing toxicity of components that humans are exposed to. The 
approach of this thesis has been both to use isolated cells in culture (in vitro) as well as 
to study humans (in vivo) after exposure to particles (study I-IV and study V, 
respectively). Chemical studies (non-cellular) where cellular components, such as bases 
of DNA, or enzymes, have been exposed to metal containing particles (study III) are 
also part of this thesis. Particle characterisation, important for understanding the 
toxicity (studies I-IV), as well as the air monitoring during the study of human 
exposure (study V) are self-evident parts of the studies included in this thesis. 
 
 
3.1.1 Exposure of cells, in vitro  
When investigating the underlying mechanisms of particle exposure on the 
respiratory system, studies of exposed cells in culture are commonly used. Cell 
cultures serve as a simplified model system of exposure and can give answers to 
fundamental questions concerning e.g. particle-cell interaction, toxic potential of 
particles and they can put light on underlying mechanisms. Advantages of cell studies 
include that cellular functions and molecular pathways can be studied in a controlled 
and simplified way. The fact that cell lines often are stabile and homogenous makes it 
easier to reproduce experiments compared to studies of primary cells, organ exposure 
or in vivo studies. On the other hand, a homogenous cell culture is also a disadvantage 
since the cells lack phenotypic differentiation, and since the effects seen are effects of 
that particular strain of cells only. An in vitro system can not replace or reproduce 
exactly what happens in the lung or in humans, but if the limitations of the in vitro 
procedure are taken into consideration and the cell lines are used in a proper way, 
they can be an excellent tool for answering basic questions and for understanding 
underlying mechanism of toxicity. Cell lines may help to understand what and why 
effects are seen in vivo. Cell culture can also be a good tool for screening of particle 
toxicity before animal studies are conducted and hence it may prevent some animal 
sacrifices. According to the three Rs (Replacement, Reduction and Refinement) 
animal tests should be avoided when possible 136, and in vitro studies may be useful 
for this matter.  
In vitro studies can be very valuable in hazard assessment, when evaluating if a 
certain particle may cause toxicity. However, to be able to make a complete risk 
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assessment of exposure, in vitro studies need to be complemented with information 
about possible exposure scenarios (if there are any risk of getting exposed), and in 
some cases the in vitro data needs to be verified by studies in vivo. 
In this thesis, the focus is mainly at hazards (toxicity) and in the in vitro studies 
(studies I-IV) two human lung cell lines have been used: A549 and BEAS-2B.  
 
A549 originates from a human lung carcinoma and has been used since 1972 when it 
was established 137. The cell line has been thoroughly characterised 138 and is one of 
the most commonly used in vitro models when studying toxic effects of PM 139. It is a 
lung epithelial cell line with structural and biochemical characteristics of type II 
alveolar epithelial cells 138 that are found in the alveoli of the lung. The type II cells are 
plump and secrete surfactant that creates a thin film on the inner surface of the lung, 
reducing surface tension. Type II cells are interspersed among the more frequent type I 
cells, which are the thin cells allowing gas exchange (see Figure 3).  
 
BEAS-2B was originally derived in 1988 from normal human bronchial epithelial 
cells immortalised using the adenovirus 12-simian virus 40 hybrid virus (Ad12-SV40 
hybrid virus) 140. These cells have characteristics of the epithelial cells of the bronchi 
and have often been used to study airway epithelial structure and function.  
In the particle exposure studies of these cells (studies I-IV) the cells were grown in 
well-plates, in cell medium (supplemented with FBS, penicillin-streptomycin and 
sodium pyruvate) and in a humidified environment imitating the physiological 
atmosphere in the lung with 37°C and 5% CO2. The general exposure procedure and 
toxicity testing for studies I-IV is illustrated in Figure 6. 
 
 
Figure 6. Illustration of the general approach in studies I-IV, which includes preparation of a 
particle suspension from dry particle powder and subsequent exposure of cells in culture. After 
a certain time of exposure the toxicity is evaluated.  
 
 
3.1.2 Chemical studies, in vitro 
To get a deeper understanding of how cellular components may interact with particles, 
studies where no cells are present can be conducted. Such studies can include bases of 
DNA or enzymes of the DNA repair system, and these components can be incubated 
with particles in order to understand what happens when they are in direct contact with 
each other. The advantage of this procedure is that no other components of the cell may 
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interfere. This approach was used in study III, where particles were incubated with the 
DNA base guanine (dG) and the DNA repair enzyme FPG. The general approach for 
the chemical studies is illustrated in Figure 7.  
 
 
Figure 7. Illustration of the general approach used in study III for the chemical studies in vitro. 
A particle suspension is prepared from dry powder followed by incubation with cellular 
components such as DNA bases (dG) or enzymes (FPG). After a certain time the effects of 
particle interaction is measured. 
 
 
3.1.3 Studies of human exposure, in vivo 
The ultimate goal for studies of particle toxicity is to understand what happens in the 
human body due to the exposure. To evaluate possible health effects in humans that 
have been exposed to particles under controlled conditions, is as close as we can get in 
order to understand the real exposure. However, these kind of studies complicates the 
picture since the body is complex in itself, and since humans are different to each other. 
It is also difficult to know if there are any confounding factors present, if the study 
population evaluated is large enough for effects to be caught and if the markers of 
effect that have been chosen really are the ones that reflect what happens in the body. 
Despite this, a human study with a well thought-out design can give a lot of valuable 
information for the prediction of what would actually happen in a real life exposure of 
humans.  
 
In study V of this thesis, a human study with a randomised crossover design was 
conducted. Eighteen healthy, non-smoking volunteers fulfilled the inclusion criteria and 
were included in the study. All participants gave their informed written consent to 
participate in the study (prior to start), which was approved by the Regional Ethical 
Review Board in Stockholm, Sweden. In this study the study subjects were exposed to 
both a subway environment with particle-contaminated air on one occasion and to clean 
air in an office on another occasion, with some weeks in between. The study was 
randomised, which means that it was decided by chance which exposure each subject 
should start with. The design allowed for the subjects to be their own control, opposed 
to the study design of so called case-control studies were subjects are allocated to be 
either a “control” or a “case”, in which the case group could be e.g. exposed to 
particles. The advantage of subjects being their own control is that the same individual 
is compared throughout the study. This rules out many confounding factors that may 
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arise due to mismatch of the case and control groups, including age and weight 
differences etc, in case-control studies. This approach also requires fewer subjects. The 
disadvantage of letting the study subjects be their own control is, however, that there 
might be so called drop-over effects from the exposure, meaning that effects from the 
first exposure is still present at the second exposure. The general study approach for the 
human study (study V) is illustrated in Figure 8. For more details of the study design, 
see paper V. 
 
 
Figure 8. Illustration of the general study approach in study V. The human exposure of 
particle-contaminated air took place at a subway station, and blood samples as well as other 
data were collected at different time points for analysis of toxic effects. 
 
 
3.2 PARTICLE CHARACTERISATION AND AIR MONITORING 
In particle toxicology studies, it is necessary to characterise the particles thoroughly. In 
the studies summarised in this thesis the particle characterisation as well as evaluation 
of the air exposure in the human study, have been conducted using inter-disciplinary 
collaborations. Researchers from the Divison for Surface and Corrosion Science at the 
Royal Institute of Technology (KTH) in Stockholm, assistance from the electron 
microscopy unit EMil at Karolinska Institutet and the expertise from co-authors have 
been used to gain an overall understanding of physicochemical properties of the 
particles investigated, as well as the air inhaled at the subway station. 
 
 
3.2.1 Particle size and morphology 
3.2.1.1 Electron microscopes 
The use of microscopes and microscopic images can give information on both size and 
morphology of particles. Ordinary light microscopes use wavelengths within the visible 
light range to image a sample, and they can often magnify a sample up to 1500 times. 
Due to the wavelengths used and hence the resolution limitation, objects smaller than 
200 nanometres are not possible to detect with these devices. To be able to see objects 
in this size or smaller a shorter wavelength is needed. In comparison to the photons 
often used in light microscopes, electrons have a wavelength, which is 100 000 times 
shorter. Electron microscopes consequently have a greater resolution than optical 
microscopes and enable the analysis of structures down to the lower nanometre size 
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scale. In the present thesis, two microscopic techniques have been used to analyse 
particle size and morphology:  
 
Transmission electron microscopy (TEM) was used to study the particle size and 
morphology in studies I-III. TEM uses a beam of electrons that transmit through the 
object and the transmitted electrons are detected creating an image (see Figure 9, left). 
TEM requires a thin, electron-transmitting sample and the darker the image, the less 
electrons have been transmitted through the sample (thicker particles).  
 
Scanning electron microscopy (SEM) was used in study IV for micrometre sized 
particles and it provides high resolution images of the surface of the object investigated 
(see Figure 9, right). It has a greater depth of focus and hence gives a more spatially 
resolved image than TEM. In a SEM a high-energy beam of electrons is focused on the 
surface of the sample which then scans the object using a regular pattern. The 
resolution can be between 1-20 nm. SEM can image a large area and the thickness of 
the sample is not as crucial. 
 
 
Figure 9. TEM image of magnetite nanoparticles (left) and SEM image of chromium (right). 
Magnetite nanoparticles are studied in studies I-III and chromium (Cr fine) in study IV. 
 
3.2.1.2 Particle size in solution 
Microscopic images of particles give information of particle size and morphology at 
dry conditions. However, particles are often in solution when evaluated in in vitro 
studies or in contact with liquid when deposited in the lining of the lungs. Particles in 
nanometre size often agglomerate in a liquid, creating agglomerates. The extent of 
agglomeration depends on several factors, such as the composition of the liquid, the 
concentration of particles, the surface charge and surface groups of the particles. How 
particles react in liquid is of importance when it comes to toxicity and cellular uptake.   
 
Dynamic light scattering (DLS) was used to measure size of nanoparticles and 
agglomerates in supplemented cell medium in studies I-III, by the means of light 
scattering. The particle size was calculated from the Brownian motion of the particles 
(the random movements of particles in liquid or gas resulting from the bombardment of 
the fast moving atoms and molecules in the liquid or gas) using the Stoke-Einstein 
equation. The method gives a hydrodynamic diameter of the particles, which is a 
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calculated particle diameter of a sphere that has the same measured motion in solution 
as the actual particle. Particles in micrometre size are difficult to measure by DLS due 
to sedimentation. 
 
Low angle laser light scattering (LALLS), which is a laser diffraction technique, was 
used in study IV to measure particle size in phosphate buffered saline (PBS). LALLS 
has the ability to measure particles in μm size. 
 
 
3.2.2 Surface area and charge 
3.2.2.1 Surface area 
When it comes to nanotoxicology, surface area is a highly debated characteristic of 
particles. It is often discussed in the context of being an important factor for the toxicity 
due to the fact that the surface area becomes larger in relation to the mass of the particle 
when the particle decreases in size. If the same mass of nanoparticles and 
microparticles are compared, the total surface area per mass is much larger for the 
smaller particles. If the surface present reactive features and if surface reactions are 
important for toxic effects, there will most likely be a larger toxic effect from the 
nanoparticles than from the larger particles. 
 
Brunauer Emmet Teller (BET) analysis was used in studies I-IV to measure the particle 
surface area. In most cases the research team of KTH was responsible for the 
measurements of the BET area and this information was only rarely taken from the 
manufacturer of the particles. BET analysis estimates the particle surface area by using 
the adsorbed amount of nitrogen on the particles at cryogenic conditions. Since the size 
of the nitrogen atom, the amount adsorbed and the mass of the particle is known, the 
surface area can be calculated. BET analysis is performed with dry powder and the 
weak forces within agglomerates do not interfere with the measurements of the 
individual particles in the agglomerate.  
 
3.2.2.2 Zeta potential 
Most particles will acquire a surface charge 
in liquid, which is due to either ionisation 
of the surface or adsorption of charged 
species. The charge of the surface will 
result in an ion layer around the particle that 
is different to the rest of the surrounding 
liquid. The ion layer is stable and when the 
particle moves in the liquid (e.g. by 
Brownian motions) the layer will follow. 
The electrical potential created between the 
charged groups associated with the particle 
surface and the liquid is called the zeta 
potential (or ζ-potential) (see Figure 10).  
 
Figure 10. A schematic illustration of zeta potential. This figure is reproduced from 141 with the 
permission from Malvern instruments Ltd. 
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The zeta potential is sensitive to the components present in the liquid, and to the pH of 
the solution. The zeta potential influences which interactions that may occur between 
the particle and different components of the liquid, or with other particles. Particles 
with high zeta potential of the same charge (negative or positive) will cause a repulsive 
force, meaning that particles with a high zeta potential will remain dispersed in a 
solution. The zeta potential is hence a determinant for particle agglomeration, but also 
for the attachment of biological components to the particle creating a so-called corona 
around the particle. 
 
Using the same instrument as for the DLS measurement, the zeta potential of particle 
suspensions were analysed in study I and III, by means of electrophoresis. The zeta 
potential is measured by applying an electric field through the solution containing 
particles, and allowing the particles to migrate towards an electrode. Dependent on 
the zeta potential, the particles will migrate at different speeds towards the electrode 
of the opposite charge, which is measured and converted to zeta potential using 
Smoluchowski’s theory.  
 
 
3.2.3 Air monitoring 
 
Monitoring of the air in the human study (study V), at the subway station (Odenplan 
in Stockholm) and at the control environment (a clean office at the Karolinska 
University Hospital in Solna) was performed during each exposure session. Particle 
mass and number concentration in air were measured with the equipment listed in 
Table 1.   
 
Table. 1. For monitoring of the air in the human study (study V) stationary and portable 
instruments were used for measurements at the subway station. For the measurements at the 
control environment only portable instruments were used. 
Equipment 
 
Measurement Particle size Additional information 
Stationary 
instruments 
Used at the subway exposure 
Harvard impactors Mass concentration, 
µg/m3 
PM2.5 and PM10 
 
Upper 50% cutoff 
aerodynamic diameter of 2.5 and 10 
µm, respectively 
 
Teflon filters with a pore size of 2 µm 
and a flow rate of 10 L/min was used 
Scanning Mobility 
Particle Sizer (SMPS) 
system 
Number 
concentration, 
particles/mL 
Ultrafine particles: 
diameter 10-100 
nm 
 
Consisting of an 
Electrostatic Classifier model 3081 in 
combination with a Condensation 
Particle Counter model 3010 (TSI) 
Portable 
instruments 
Used at the control and subway 
exposure 
DataRAM Mass concentration, 
µg/m3  
PM10 
P-Trak Number 
concentration, 
particles/mL 
Ultrafine particles: 
diameter 20-1000 
nm 
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Previous studies in the same subway environment 65,142 have used the sample filters 
from the Harvard impactor to analyse which metals that were present in the air. 
 
NO and NO2 measured with chemiluminescence instrument AC 31M and relative air 
humidity as well as temperature were also monitored at the subway station during 
each exposure session.  
 
Personal exposure to NO2 (indicator of air pollution exposure) was measured during 
both control and subway exposures and the following 24 hours, with a passive diffusion 
monitor carried by each subject. The time spent outdoors during this period was also 
stated.  
 
 
3.3 TOXICITY TESTING 
The essence of particle toxicology lies in the toxicity testing. Products of oxidative 
stress, inflammation and damage to DNA can be used as markers for indication of 
damage caused by particle exposure. This part of the thesis will therefore describe the 
different toxicity assays used to measure relevant markers of toxicity. In this context 
assays used for the cellular studies (studies I-IV) as well as the human study (study V) 
will be considered.  
 
 
3.3.1 Particle exposure in vitro - dose, time and sample preparation 
To mimic a pulmonary exposure of particles, the cultured human lung cell lines A549 
and BEAS-2B were used in the in vitro studies (studies I-IV).  
 
Exposure dose and time 
To set a dose for the particle exposure in in vitro studies can be very tricky, as 
previously discussed in the introduction section of this thesis. As discussed by 
Oberdorster et al. 10, it is often tempting to use a rather high dose without any 
consideration of whether it is relevant for an in vivo exposure or not. In a study by 
Risom et al 111, calculations were made in an attempt to conclude what the doses that 
have been seen to cause oxidative damage to DNA of cells in in vitro studies would 
correspond to in a human situation, as lung exposure. The dose of 25 μg/well in in vitro 
exposure was shown to correspond to 3.7 years of exposure to a typical ambient 
concentration of ultrafine particles 111. The conclusion was that the doses used in vitro 
exceed what is believed to be realistic in a real exposure scenario. When exposing cells 
in vitro to particles in solution it might, however, be important to consider the 
possibility that not all nanoparticles in a sample will sediment due to their small size. 
Consequently, the cells might not be exposed to the full intended dose.  
 
The use of high doses is often defended by the idea that the high dose does not matter 
as long as there is a mechanistic pathway being studied. However, Oberdorster state 
that that is likely to be untrue and that the mechanisms operating at low doses are likely 
to be different from when the cellular system is overwhelmed with a high particle dose. 
In a study by Kroll et al. 143 a dose range between 0.1 and 10 μg/cm2 was calculated 
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from exposure studies in vivo and suggested to be relevant for use in in vitro studies. 
Nonetheless, what is a realistic exposure dose? How high can the dose be in hot spots 
of the lungs? There are so many unanswered questions regarding this issue at present. 
One way to cope with this issue is to evaluate cellular responses in vitro to different 
doses, low to high, hence evaluating if there is a dose response or not. In studies I-IV 
the doses range from 5 – 40 μg/cm2, but most often doses of 20 and 40 μg/cm2 have 
been used. These are probably somewhat high doses, but they are, however, 
undoubtedly far from being the highest used in particle toxicity testing performed 
worldwide. 
 
Furthermore, to estimate a relevant exposure time can also provide a challenge in in 
vitro studies. Dependent on the mechanism studied, it is important that the time is long 
enough for a certain cellular response to be initiated. Regarding exposure time in the 
studies of this thesis, the exposure times vary depending on the toxicity test performed 
and range from short exposure of 1 h to longer exposure times of up to 24 h. 
 
Sample preparation 
For the in vitro exposure of lung cell lines, the particles of interest were mixed with cell 
medium. Characteristics of the cell medium can vary in terms of ionic strength, pH etc., 
and it contains a mixture of nutritional components such as serum proteins, which is 
needed for growth and living of the cells. To mix particles in cell medium upon 
exposure is a common procedure used in in vitro toxicity testing of particles. However, 
the characteristics of cell medium have been shown to influence particle dispersion and 
agglomeration 144. Some particles may tend to agglomerate in cell medium, causing the 
formation of larger complexes of particles. The forces that agglomerate the particles are 
often weak and ultrasonication, which is a method that sends ultrasound through the 
suspension, can be used to separate the particles just before the start of cellular 
exposure. During sonication, bubbles are formed that, when collapsing at the solid 
surface of the agglomerate, cause breakage of agglomerates 145. This separation may, 
however, be temporarily since re-agglomeration may occur. Sonication using a probe 
was used in studies I-III and a bath was used for sonication in study IV.  
 
 
3.3.2 Cell viability - cytotoxicity 
Cytotoxicity is a word explaining the toxicity of a substance to the cell. Often 
cytotoxicity is measured as a decrease in cell viability i.e. the amount of cells that die. 
This death is often referred to as either being caused by controlled apoptosis or 
uncontrolled necrosis 146. However, it may not be that simple and 13 different types of 
cell deaths have in fact been suggested 147. There are several available methods to use 
to evaluate cell viability in vitro after particle exposure, some more precise than others 
in catching the different types of cell death. 
 
Cell membrane integrity is one way to study and evaluate cytotoxic effects. One 
classical method in doing so is to study the exclusion of the dye trypan blue from cells 
148. Trypan blue does normally not penetrate the cell membrane. If the cell membrane is 
damaged, however, the die penetrates the membrane and the cell will attain the colour 
blue. Damaged and undamaged cells can subsequently be visualised microscopically. 
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The result is frequently expressed as the % of damaged (non-viable) cells of the total 
cell count. Since this method measures the amount of cells with a disrupted membranes 
the cells do not necessarily need to be dead per se. 149 and discrimination between 
necrosis and apoptosis is not possible. Nonetheless, trypan blue staining is a well used 
method and is considered to measure necrosis and cells in late apoptosis. One way to 
specifically measure apoptosis is to look at caspase levels in cells, which is important in 
the event of apoptosis 148. Other ways to study cell membrane integrity include to 
measure the leakage of cellular components such as e.g. lactate dehydrogenase (LDH).  
 
Another indicator which is often used for cytotoxicity evaluation is the tetrazolium salt 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT). MTT is reduced 
by dehydrogenases to formazan in the mitochondria of living cells 150. The end product 
is purple and is measured by light absorbance in a spectrophotometer. In the MTT-
assay the metabolic activity (viability) of the exposed cells is compared to that of 
unexposed cells.  
 
In this thesis, toxicity testing using the trypan blue method has mainly been used. Both 
in the context of evaluating the cytotoxicity of particle exposure (study I, II and IV) and 
prior to evaluation of DNA damage using the comet assay, assuring a high percentage 
of viable cells prior the comet assay. 
 
 
3.3.3 Intracellular ROS 
One challenge when studying ROS is their short lifetime 101. Analysis of stabile end-
products from oxidation can therefore be favourable, and can be used to give an 
estimate of the oxidative stress level in a cell. To detect the amount of ROS in vitro 
despite their short lifetime, fluorescent probes may be used. One of the most commonly 
used fluorescent probe is 2’,7’-dichlorofluorescin diacetate (DCFH-DA). This probe 
easily penetrates the cell membrane, and upon entering the cell the DA groups of the 
molecule become enzymatically cleaved. DCFH is then oxidised to dichlorofluorescin 
(DCF) by ROS and it is not until this moment that the probe becomes fluorescent. The 
fluorescence can be measured by e.g. a computerised microplate fluorometer or a flow 
cytometer. This method measures general oxidative stress rather than any specific kind 
of ROS. DCFH-DA was used in studies I and III of the present thesis. 
 
 
3.3.4 Damage of DNA 
HPLC-EC/UV system 
High performance liquid chromatography (HPLC) coupled to electrochemical (EC) 
and ultraviolet (UV) detection can be used to measure the formation of 8-oxodG 151. 
In this approach, 8-oxodG and undamaged dG are separately detected by the EC 
detector and UV detector, respectively. From this method the amount of 8-oxodG in 
relation to undamaged dG is calculated and is reported as 8-oxodG/106 dG. The 
creation of artificial oxidation during the sample preparation is one disadvantage of 
this method. However, the method is considered specific and has been evaluated by 
the European Standards Committee on Oxidative DNA Damage (ESCODD) 152. This 
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method was used in study III for evaluation of the formation of 8-oxodG by particle 
exposure of dG. 
Comet assay 
A frequently used method for measuring DNA damage is the comet assay 153. It is 
considered to be a well-established method and has been evaluated in ESCODD 154 as 
well as in the European Comet assay Validation Group (ECVAG)155-157 working 
within the frame of the European Network of Excellence: Environmental Cancer risk, 
Nutrition and Individual Susceptibility (ECNIS). The first version of the assay was 
developed in 1984 by Östling and colleagues for the detection of SSB and DSB 158 
and some years later further developments were made by Singh et al. 159 for the 
measurement of additional alkali labile sites (ALS) under alkaline conditions. In 
recent years, the method has been increasingly used when evaluating DNA damage in 
in vitro studies of nanoparticle exposure 160. 
 
The version of the comet assay most often used is the alkaline comet assay that 
measures DNA damage, predominantly in the form of SSB and ALS. An ALS is a site 
on the DNA that, due to damage such as a missing base, will break if it is exposed to 
high alkaline pH. By adding glycosylases, such as FPG or hOGG1, that find specific 
types of lesions, the method is also a great tool to analyse oxidative DNA damage and 
oxidative stress.  
 
In the comet assay (procedure illustrated in Figure 11), cells that have been exposed to 
e.g. particles are embedded in agarose on a microscope slide. Then the cells are lysed 
with detergents and high salt that liberates the DNA from the histones. Alkaline 
treatment unwinds the DNA and the high pH also contributes to SSB being formed at 
ALS. During the subsequent electrophoresis at high pH, the breaks in DNA contribute 
to the extension of so called DNA loops from the nucleoid, creating a comet like shape 
with a “head” and a “tail” (see Figure 11). This happens since the negatively charged 
DNA moves from the nucleoid (head) of the cell towards the anode of the 
electrophoresis. Following the electrophoresis, the gel is neutralised and fixed with 
methanol. To be able to visualise the DNA, the gel can be stained for example with the 
fluorescing dye ethidium bromide (EtBr) and analysed in a microscope using a 
computer software. The more DNA breaks present, the more DNA will be found in the 
tail. To estimate the amount of DNA damage, the tail of the comet is measured. Several 
units exist for this measurement, including tail moment, tail length and %DNA in tail. 
%DNA in tail has been recommended by Collins et al. as the preferred unit 161. It 
reflects the percentage of DNA in the tail relative to the amount of DNA in the comet 
head, and is the unit used within this thesis.  
 
To specifically analyse oxidatively damaged DNA, enzymes such as human OGG1 
(hOGG1) and E. coli FPG can be used to find oxidised purines, such as 8-oxoguanine. 
hOGG1 has been suggested to recognises 8-oxoguanine with a higher specificity than 
FPG 162. FPG primarily recognises 8-oxoguanine, fapy-guanine and fapy-adenine 163. 
The enzyme is added and the cells are incubated in the comet assay before the alkaline 
treatment. The enzyme removes the lesion, creates an abasic site, which is converted to 
a strand break either by the enzyme´s associated lyase activity or by the alkaline 
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treatment. Since the other factors that are needed for repair are not present in the human 
cells at this stage of the assay, the FPG or hOGG1 enzyme will only perform this first 
step of the repair process, generating SSB and ALS. If the cells with and without the 
addition of the enzyme are compared, the amount of oxidative damage can be 
calculated by the following formula: 
 
% DNA in tail (enzyme treated) - % DNA in tail (without enzyme) = oxidatively damaged DNA 
 
 
The comet assay was used for the evaluation of DNA damage in all studies of this 
thesis, both for in vitro and in vivo samples. For evaluation of oxidative DNA damage, 
the FPG enzyme was used in study I, II, III and V. hOGG1 has been evaluated, but the 
results have not been published yet and will instead be discussed in the 
result/discussion section of this thesis.  
 
 
3.3.5 DNA repair – hOGG1 activity 
The effect of particle exposure on DNA repair (BER) or hOGG1 activity can be 
measured by a modified version of the comet assay 164. In this version, DNA repair 
enzymes are extracted from cells, often peripheral blood mononuclear cells (PBMC) 
from blood of exposed humans. The sample of extracted enzymes is added after lysis 
in the comet assay, and its ability to find oxidatively damaged DNA in pre-damaged 
cells (damaged by a so called photosensitiser causing specific oxidative damage to 
DNA) can be evaluated. This makes it possible to detect whether the level of repair 
enzymes is elevated or not after a certain exposure. This repair assay is a new and 
promising technique. However, no standardised protocol exists. Nonetheless, a 
validation study has been performed by ECVAG, in which the reliability and 
reproducibility of the assay was evaluated 165. The method has been used in some 
human studies of exposure to particles 166,167 and will likely be increasingly used in 
the future. DNA repair was evaluated in the human study (study V) of the present 
thesis (see Figure 11 for illustration of the procedure). 
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Figure 11. Procedures for the different versions of the comet assay. Cells exposed to 
particles or the photosensitiser Ro (creating oxidatively damaged DNA when exposed to 
light) are mixed with agarose and added to a microscope glass before lysis. For evaluation of 
SSB and ALS no enzyme is added after lysis (A), for evaluation of oxidative damage from 
particle exposure FPG or hOGG1 enzyme is added (B). For evaluation of the DNA repair in 
PBMC from human subjects, exposed to particles, an enzyme extract from these cells is 
added (C) to Ro exposed cells after lysis. Then alkali unwinding, electrophoresis and staining 
are performed. Finally, the cells are analysed microscopically using a computer software. 
The image of the comets at the bottom illustrates cells with increasing amounts of damage. 
For the repair assay (C), low levels of damage means that the repair has been disrupted 
since it can not find the damage that exists in the Ro exposed cells. 
 
3.3.6 Mitochondrial depolarisation 
Mitochondrial depolarisation is a cellular event where the negative potential (caused 
by the electron transport chain) of the mitochondria is disrupted. Mitochondrial 
depolarisation is important in apoptosis 146 and has also been shown to be involved in 
necrosis caused by nanoparticles 168. Damage to mitochondria can also cause release 
of ROS, hence damage to mitochondria is highly relevant also for several other 
possible damages to the cell. 
 
For analysis of mitochondrial depolarisation the fluorescent probe tetramethyl-
rhodamine ethyl ester (TMRE) can be used. TMRE is a cationic lipophilic dye, which 
 
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accumulates in the negatively charged mitochondrial matrix. To analyse the 
accumulation of TMRE, a fluorescence-activated cell sorting (FACS) instrument can 
be used. If the potential is lost (i.e. the mitochondria are damaged) no fluorescence 
will be seen. Mitochondrial depolarisation was evaluated in study II. 
 
 
3.3.7 Haemolysis 
Surface reactivity of particles can be analysed by determining the ability of the 
particles to cause haemolysis of red blood cells. The haemolysis is considered to be 
caused by direct interactions of particle surface with the red blood cell, which can 
possibly be driven by oxidative stress on the surface 169. In the assay, particles are 
incubated with red blood cells (often from human donors) and the amount of 
haemoglobin released is determined by a spectrophotometer. In the assay, the amount 
of haemoglobin is compared to that of cells that have been incubated with the 
detergent Triton X100 that causes 100% lysis. This method is often used to 
investigate the reactivity of particle surfaces, but can also be seen as a method to 
evaluate the toxicity of particles towards red blood cells. Additionally, a study by Lu 
et al. 170 evaluating the toxicity of different metal oxide nanoparticles has shown that 
the results from this haemolytic assay could, in almost all cases, predict the 
inflammation outcome from lung installation in rats of the same particles. 
 
 
3.3.8 Inflammation 
In the present thesis, markers for inflammation were measured in the human exposure 
study (study V).  
 
Cell differentiation 
Cell differentiation counts or concentration of neutrophils, eosinophils, basophils, 
lymphocytes and monocytes in blood can give information about inflammation status in 
the body. In healthy persons the concentration of neutrophils lies between 40-60%, 
lymphocytes 20-40%, monocytes 2-8%, eosinophils 1-4% and basophils 0.5-1%. In 
study V this was measured in blood samples after subway air exposure according to 
common procedure using an auto-analyser.  
 
Lymphocyte subsets 
A useful procedure to distinguish between types of lymphocytes, their stage of 
differentiation and activity in blood is by the presence (+) or absence (-) of certain 
cellular surface markers called cluster of differentiation (CD) markers. There are 
several hundreds of different CD markers 115. Tests using monoclonal antibodies 
against specific CD molecules can be used for the detection of CD markers of interest. 
In the human study (study V), a so called TBNK 6-color Multitest, consisting of 
antibodies for T-cells, B-cells and Natural killer (NK) cells was used to determine 
lymphocyte subsets. In addition, separate monoclonal antibodies were used for further 
phenotypic characterisation (T-cells activity and regulatory functions). Since the 
antibodies were conjugated with a flouorochrome the results could be analysed by a 
FACS, evaluating approximately 2.5 x 105 cells from each sample. For the TBNK test, 
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a gate was set (a selection was made 
during the evaluation of the FACS-
results) for CD45 (leukocytes). For the 
evaluation of T-cell activation and 
analysis of T-regulatory cells a gate 
was set for CD3 (T-cells). The CD 
markers measured in study V, are 
listed in table 2. 
 
Table 2. The following CD markers and 
the intra-cellular transcription factor 
Foxp3 were studied in the human 
exposure study (study V). Evaluation of 
the lymphocyte subsets in blood can give 
information about possible inflammation 
responses. 
 
 
Fibrinogen 
The plasma glycoprotein fibrinogen is an important factor in normal blood clotting. 
Fibrinogen is also a so called acute-phase protein which initiates immune functions, 
and its levels have been seen to be elevated during inflammation 171. The 
concentration in plasma is often analysed as a routine at hospital laboratories. This 
was also the case in study V where a kinetic fibrinogen assay was used. 
 
3.3.9 Other human health markers – lung permeability, lung function, self 
graded symptoms 
In the human exposure study (study V), some additional health markers were studied, 
as will be described below. 
 
Lung permeability 
Clara cells, located in the lining of the airways (see Figure 3), release clara cells 
protein 16 (CC16) upon damages of the lung epithelium. Release of CC16 can be 
masured in serum and is used as a marker for lung epithelial damage, as well as for 
lung permeability. To measure CC16 in serum, enzyme-linked immunosorbent assay 
(ELISA) can be used. In this assay, CC16 in blood is allowed to bind to antibodies 
bound in wells of a plate. After washing, an antibody and a conjugated streptavidin-
horseradish peroxidase is added and an enzyme-dependent colour-change reaction 
catalysed by peroxidases then makes it possible to measure the presence of CC16. The 
result is evaluated using a spectrophotometer.  
Lung function test  
Prior to the inclusion in the human study (study V) all subjects underwent a routine 
physical examination and a lung function test with a spirometer, measuring vital 
capacity (VC), forced vital capacity (FVC) and forced expiratory volume during the 
General markers 
 CD45 White blood cells (leukocytes) 
 CD69 Early activation of lymphocytes 
 CD27 Co-stimulator for T and B-cells 
  T-cells markers 
 CD3 T-cells 
 CD4 T-helper/inducer cells 
 CD8 T-cytotoxic/suppressor cells 
 CD25 Early activation of T-cells 
 Foxp3 T-regulatory cells 
 CD25/Foxp3 T-regulatory cells 
B-cells markers 
 CD19 B-cells 
NK-cells markers 
CD56+/CD16+  NK or NKT-cells 
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first second (FEV1). This was performed to assure that the study subjects were without 
any symptoms of disease of the respiratory system.  
 
During the study, lung function test was performed with a portable lung health monitor, 
measuring peak expiratory flow (PEF). PEF is the maximum speed of expiration 
measured in litre/min and it can be used to measure changes in the degree of 
obstruction of the airways. 
 
Self graded symptoms 
Using a Visual Analogue Scale (VAS), study subjects can evaluate their symptoms 
during a study 172. In study V the following symptoms were graded at a scale from 0-10 
(where 0 correspond to no symptoms and 10 to severe symptoms): irritation from eyes, 
nose, lower airways and experience of disturbing smell. 
 
 
3.3.10 Interference of particles with toxicity assays  
Many traditional in vitro toxicity assays were designed for testing of chemicals not 
particles. Since particles display unique physicochemical properties due to their 
solidity, i.e. size, shape, agglomeration properties, surface area etc. they are different to 
chemicals. The unique properties of particles may lead to interaction in assays, a fact 
that has been discussed especially within the field of nanotoxicology 173. Interference of 
particles in test methods may give both false positive and false negative results. 
Nanoparticles can, for example, have optical absorbance at the same wavelength as a 
coloured product that is measured in an assay, or they may adsorb dyes that are to be 
measured. Reaction between the particle surface and a dye, as well as magnetic 
properties of the particle may also be issues 174. In the concept of the studies of this 
thesis, particle interactions with the assays used have been evaluated when possible. 
One example is the discovery of autofluorescence of TiO2 particles, interfering with the 
results of the assay evaluating intracellular ROS levels by DCFH-DA. Possible 
interference was also seen in study III when HPLC-EC/UV was used to study oxidation 
of the DNA base guanine. This was indicated by a lower level of oxidation from some 
particles when compared to the control without particles. Moreover, interference by 
particles in the comet assay using FPG is the focus of study III. In this study an 
interaction test of particles and ions with FPG was designed as described in Figure 
12. The test contained two separate steps, as described below. 
 
Step I) A549 cells were exposed to a photosensitiser (Ro) and light irradiation, 
inducing oxidatively damaged DNA (i.e FPG sites, at a level of 40% DNA in tail). 
The damaged cells from this step were then evaluated with FPG from step II 
(described at the next page and in Figure 12).  
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Step II) FPG was pre-incubated with all particles for 30 min at 37°C and then 
centrifuged. The supernatant without the particles was then used to detect FPG sites 
of the cells from Step I using the comet assay (A) in Figure 12. This procedure 
reveals if the particles adsorb/bind FPG, in which case the enzyme is discarded at the 
centrifugation, or if FPG gets dysfunctional after contact with the particles. The 
particles that caused a lower activity of FPG (in A) were further evaluated in 
procedure (B) and (C) (see Figure 12). In (B), FPG was mixed with the particles and 
directly used in the comet assay for detection of oxidatively damaged DNA. The 
results indicate if FPG still works despite being bound to the particle. In (C), the 
particles were incubated in buffer for 30 min for possible release of ions. The 
particles were centrifuged away and the released ions (if any) were incubated with 
FPG for 30 min. This procedure shows if the detected inhibition of FPG was due to 
released ions. 
 
 
 
Figure 12. Procedure in study III, analysing particle and ion interaction with FPG in the comet 
assay. 
  43
4 RESULTS AND DISCUSSION – PARTICLE TOXICITY 
 
The following text will summarise and discuss the results from the studies I-V  within 
this thesis (for details see paper I-V). The chapter begins with an evaluation of the 
importance of chemical composition, size, surface area, charge, metal ion release and 
protein corona for toxicity and interaction of metal containing particles with biological 
systems. Methodological interference of particles with the comet assay, when 
measuring oxidatively damaged DNA in cells, will also be presented and discussed, as 
well as some other considerations for the comet assay when measuring oxidatively 
damaged DNA. Finally, the results from the study of human exposure to metal 
containing particles in the subway system will be highlighted as an example of human 
exposure to metal containing particles. The conclusions that are made in this section are 
not necessarily the conclusions of the co-authors of the published papers, but rather 
reflections made by the author of this thesis. 
 
 
4.1 THE ROLE OF CHEMICAL COMPOSITION 
In studies I, II and III of this thesis, toxicity and underlying mechanisms of toxicity of 
totally 12 nanoparticles and one nanofibre were evaluated. Human lung epithelial A549 
cells and bronchial epithelium BEAS-2B cells (only in study III) were exposed in 
culture and the parameters tested were cytotoxicity, DNA damage, formation of 
oxidatively damaged DNA, intracellular ROS (studies I and III) and mitochondrial 
depolarisation (only study II). For more detailed information about the study design see 
the separate papers. 
 
In study I, nanoparticles of carbon black, CuO, CuZnFe2O4, Fe2O3, Fe3O4, TiO2 and 
ZnO, as well as multiwalled carbon nanotubes (MWCNT) were compared. The toxicity 
evaluation showed a high variability of toxicity from the exposure of the different metal 
oxides and MWCNT. The most important finding was the univocal results of the 
exposure of CuO nanoparticles, as shown in all the used toxicity tests, namely high 
cytotoxicity, DNA damage and oxidatively damaged DNA. The toxicity of CuO was 
always the highest when compared to the other metal oxides as well as MWCNT. 
However, toxicity was also seen after exposure to some of the other nanoparticles: 
cytotoxicity after exposure to Fe2O3, CuZnFe2O4, MWCNT and ZnO, DNA damage 
from ZnO, MWCNT, CuZnFe2O4 and TiO2, and oxidatively damaged DNA by ZnO, 
Fe3O4 and CuZnFe2O4 exposure (the nanoparticles/fibre are mentioned in the order of 
lowest to highest levels of toxicity). Beyond the overall high toxicity of CuO 
nanoparticles, it was obvious that the nanoparticles affected the cells in different ways. 
For example, ZnO showed rather high cytotoxicity, but low DNA damaging effect, 
whereas TiO2 caused pronounced DNA damage but no effect on cell viability (see 
Figure 13 and 14). A conclusion from these results is that the chemical composition of 
the particles (and the fibre) seems to affect the lung cells by different mechanisms, 
resulting in different toxicological effects. The cytotoxicity results for the nanoparticles 
and MWCNT in study I can be seen in Figure 13. Figure 14 shows DNA damage from 
all evaluated nanoparticles and MWCNT in study I-III.  
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Figure 13. Cytotoxicity in cultured A549 cells after exposure to 20μg/cm2 (40 μg/mL) and 40 
μg/cm2 (80 μg/mL) nanoparticles for 18 h, measured as percent nonviable cells by trypan 
blue staining. The asterisks (*, **, ***) indicate significantly higher levels compared to 
controls and correspond to p < 0.05, 0.01, 0.001, respectively. For more details see paper I. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14. DNA damage in cultured A549 cells after exposure to 40 μg/cm2 (80 μg/mL) 
nanoparticles for 4 h, measured as percent DNA in tail by the comet assay. For more details, 
see paper I, II and III. 
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Redox active metals  (transition metals) of nanoparticles might be an attribute linked to 
possible toxicity. Studies suggest that transition metals present in particles, especially 
iron, generate ROS, subsequent oxidative stress and respiratory symptoms 50. In the 
studies of the present thesis, iron oxides did, however, show small or no effects on 
cultured human lung cells and they were, for that reason often used as controls with low 
toxic potential. No or low toxic effect of iron oxide particles is in agreement with 
other studies 175,176. One main explanation to this may be that only low amounts of 
redox active iron ions are dissolved from the particles intracellularly during the time 
course of the experiment. This is in contrast to CuO that rapidly dissolves in the cells 
(as will be discussed in more detail later on). A study by Limbach et al 177 reveals, 
similarly to study I of this thesis, that transition metal containing nanoparticles can 
cause quite different levels of ROS both in A549 cells and in cell free experiments. In 
that study, iron oxide also gave low levels of ROS in comparison to other transition 
metals.  
 
The high toxicity of CuO particles leading to cell death after 18 h could be a response 
to the DNA damage these particles caused, as a way to prevent a mutagenic outcome. 
It is, however, likely that a pronounced oxidative stress generated by the CuO 
particles and dissolved Cu ions, lead to cell death independently of the DNA damage. 
In a study by Wang et al. 123 primary cytotoxic responses were shown to be due to 
oxidative stress rather than DNA damage. Which specific cellular process that is the 
driving force might, however, be hard to clarify and several effects may often take 
place simultaneously. Fahmy et al. 178 have found similar results from CuO 
nanoparticle exposure of epithelial cells as presented in the studies of this thesis in 
terms of generation of ROS. The particles were additionally shown to be able to 
overwhelm antioxidant defence to a higher degree when compared to particles of 
silicon oxide and iron oxide. This is likely an important event for the formation of 
oxidatively DNA damage seen in the present thesis.  
 
The high toxicity of CuO nanoparticles seen in this thesis, is particularly alarming 
since nanoparticles of copper are used in several consumer products, as an ingredient 
in e.g. polymers, paints and bioactive coatings (with the purpose to inhibit the growth 
of microorganisms) 179. Moreover, CuO is used in antimicrobial textiles, in the same 
way as the widely used sliver 180. Furthermore, some cosmetic products available for 
consumers contain Cu nanoparticles 44. Copper is a metal that is also widely used in 
industries, particularly in the electrical sector. Emissions of copper and copper 
containing particles from smelters, iron foundries, power stations, and municipal 
incinerators 181 as well as in subway stations 69 may also cause human exposure. In 
vivo studies of Cu nanoparticles have shown acute toxicity, including severe injuries 
of the kidney, liver and spleen when mice were exposed orally 182. Additionally, rats 
exposed to CuO nanoparticles by intratracheal installation have been seen to suffer 
from acute inflammation in the lungs 183.  
 
An important finding in studies I and II concerns TiO2. Namely that TiO2 caused a 
significant increase in DNA damage both in nano- and microparticle form, which was 
not seen in the same way for the other particle types tested (see paper II). TiO2 exists 
in both anatase and rutile forms, and studies have indicated mixes of these to induce 
DNA strand breaks 184,185. In the studies of this thesis a mix of anatase and rutile TiO2 
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nanoparticles was used, and the positive results are thus in agreement with these 
studies. When mixes of anatase and rutile forms have been compared to either anatase 
or rutile forms alone, mixes have had the strongest effect on oxidatively damaged 
DNA 186 as well as on cytotoxicity measured as LDH release. It is likely that DNA 
damage from TiO2 is linked to the photocatalytic action of these particles, i.e TiO2 
can form radicals in the presence of light. It can therefore not be excluded that some 
additional damage was formed during the experimental procedure when these 
particles were evaluated within the studies of the present thesis. However, no signs of 
oxidative stress from TiO2 particles were found in our studies (studies I and II). The 
in vitro toxicity of TiO2 nanoparticles is of particular concern considering its wide use 
in sunscreens and cosmetics.  
 
In study III, the toxicity of nanoparticles of Ag, CeO2, Co3O4, Fe3O4, NiO and SiO2 in 
terms of DNA damage and oxidatively damaged DNA in both A549 and BEAS-2B 
cells was investigated. Intracellular ROS in A549 and oxidative capacity of the 
particles, measured as oxidation of the DNA base guanine in a non-cellular system, 
were also evaluated. Similar to the results reported in study I and II, the nanoparticles 
in this study also differed in toxic capacity depending on their chemical composition. 
For DNA damage, NiO showed the highest damaging effect in both cell lines, 
followed by CeO2. For NiO, the level was not too far from that seen from CuO in 
studies I and II (see Figure 14). Other studies have also reported toxic effects as a 
consequence of NiO exposure. Cultured human airway epithelial cells (HEp-2) and 
human breast cancer cells (MCF-7) have shown reduced cell viability by NiO 
nanoparticle exposure, as well as elevated oxidative stress as indicated by depletion 
of glutathione, induction of reactive oxygen species and an increase of lipid 
peroxidation, all in a dose-dependent manner 187. In that study, biomarkers of 
apoptosis were also observed to be induced, including caspase-3 enzyme activity and 
DNA fragmentation. In a study by Horie et al. 188, in which effects of NiO 
nanoparticle exposure were compared between cell cultures (A549) and after tracheal 
installation in rats, the particles were seen to induce oxidative stress in A549 and 
cause oxidative stress related injury in the rats. The conclusion was that the results of 
the in vitro and in vivo studies tended to correspond. Nanoparticles of NiO are 
increasingly being used in various applications, e.g. in alkaline batteries and as an 
electronic component. Despite this wide use and the indication of toxicity along with 
the fact that nickel compounds (including NiO) are considered carcinogenic to 
humans according to IARC 189, there is limited information concerning the toxic 
mechanisms and detailed biological responses of NiO in the form of nanoparticles. 
However, the cellular uptake of the NiO particles and intracellular release of Ni is 
likely to be important for carcinogenic potential of Ni-compounds 190. 
 
One specific aim of study III was to investigate if toxicity of nanoparticles with 
different chemical compositions was dependent on cell line, and both A549 and 
BEAS-2B were therefore tested. Especially for nanoparticles of Ag, the cell line 
seemed important for the DNA damage since positive results were seen for BEAS-2B 
whereas no damage was observed in A549 (see paper III). Fe3O4 also indicated DNA 
damage in BEAS-2B cells, but not in A549. Co3O4, CeO2 and NiO showed DNA 
damage in both cell lines. These results indicate that the cell types are affected 
slightly differently depending on the chemical composition of the particles. The fact 
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that cell lines might respond differently to exposure of nanoparticles has been shown 
in other studies as well 143,191. Furthermore, the resistance of A549 compared to other 
cell lines has been indicated for some nanoparticles 191,192. A conclusion that can be 
made is that the choice of cell model will certainly influence the findings in toxicity 
studies. 
 
In study III, significantly increased levels of intracellular ROS in A549 cells after one 
hour of particle exposure were seen for the nanoparticles of Ag, Co3O4 and NiO (see 
Figure 15). However, Co3O4 exposure in BEAS-2B was the only nanoparticle causing 
oxidatively damage to DNA measured by the comet assay. The absence of 
oxidatively DNA damage from all the other nanoparticles tested was suggested to, in 
part, be due to methodological interaction with the restriction enzyme FPG used in 
the comet assay (which will be discussed further on). The interference of Ag 
nanoparticles with FPG, which was detected, speaks for the possibility that Ag 
nanoparticles may interfere with the repair machinery for oxidatively damaged DNA, 
since FPG is a repair enzyme. ROS production and subsequent DNA damage, in the 
form of bulky DNA adducts, has been measured in A549 cells following Ag exposure 
by others 193 and oxidation of the DNA base guanine was induced by the Ag particles 
in study III (see paper III). The ability of Ag to cause oxidative DNA damage, in 
combination with possible interference with DNA repair, may give Ag nanoparticles 
a “double potential” to cause damage to DNA, direct and indirect by interaction with 
repair. It should, however, be noted that the genotoxicity of Ag nanoparticles reported 
in the literature differ, with some studies reporting pronounced toxicity whereas other 
report low or a lack of toxicity 194,195. Another metal oxide with conflicting data 
reported is CeO2, described to possess antioxidative properties as well as toxic 
properties 196. In study III, DNA damage was observed, but ROS was not significantly 
increased from CeO2 exposure. This contradicts to the results from a study by Kroll and 
colleagues 143. Three of the four types of CeO2 nanoparticles that they investigated 
showed ROS production (using the same method as in study III) in A549 cells at a dose 
representing only 25% of the dose tested in the present thesis. Thus, the toxicity of 
CeO2 seems to differ from study to study even when using the same cell line. 
Figure 15. Generation of intracellular ROS in A549 cells from particle exposure of 40μg/cm2 
(1 h), measured as DCF fluorescence. An asterisk (*) indicates p < 0.05, a significantly higher 
level corresponding to the control. The y-axis shows time increase compared to the control, 
indicated by the dotted line. For more details see paper III. 
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Chemical composition has been suggested to be more important for larger particles 
than for particles in nanometre size 111. However, the studies of this thesis and the 
discussion above highlight its importance also for toxicity of a wide range of metal 
containing nanoparticles. A conclusion that can be drawn from the results of the 
presented studies so far, is that the chemical composition of the metal containing 
particles seems to be important for the toxicity, and this thesis especially 
highlights the toxicity of CuO and NiO nanoparticles. Furthermore, the different 
chemical compositions will most likely lead to differences in charge and 
dissolution/metal ion release that may be crucial for the toxic potential. This will be 
discussed more in the next section as well as the impact of size and surface area of 
particles with the same chemical composition.   
 
 
4.2 THE ROLE OF SIZE, SURFACE AREA, CHARGE AND METAL ION 
RELEASE 
Particle size and surface area 
In study II, nanoparticles and particles in micrometre size of CuO, TiO2, Fe2O3 and 
Fe3O4 were compared in terms of their toxicity. The aim was to see if particle size was 
an important factor for toxicity when the material composition was the same. 
Cytotoxicity, mitochondrial depolarisation, DNA damage and oxidatively damaged 
DNA were the parameters evaluated after exposure to A549 cells. The results revealed 
a significantly higher toxicity for nanoparticles of CuO, when the parameters for 
cytotoxicity, mitochondrial depolarisation and DNA damage were compered to 
micrometre sized particles of the same composition. For oxidatively DNA damage 
there was also a difference, however, this difference was not of statistical significance 
when micro- and nanoparticles were compared. Norppa et al. stated in a recently 
published study 197 that it can not be generally assumed that nanoscale size would 
increase the genotoxicity of nanomaterials, or that nanoparticles are generally 
genotoxic. This is indeed in agreement with our results. Comparison of DNA damage 
from micro- and nanoparticles of Fe2O3 and TiO2 actually showed opposite results 
compared to that seen for CuO, namely a small, but significantly higher damage level 
from the micrometre sized particles (see Figure 16). For TiO2 the reason for this effect 
might be that the particle samples consisted of different crystalline structure. The 
nanoparticles were a mix of rutile and anatase, and the microparticles were rutile with a 
small amount of anatase. In an inhalation study of mice by Grassian et al. 198, it was 
shown that nanoparticles of TiO2 with a diameter of 21 nm caused significantly more 
inflammation than the particles of 5 nm. In this study too, the crystalline structure is 
discussed to partly explain the results (5 nm = anatase, 21 nm = a mix of anatase and 
rutile). Thus, for TiO2, the crystalline structure is likely to be more important for the 
toxicity than size. 
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Figure 16. Comparison of DNA 
damage in A549 cells after 4 h 
exposure to 40 μg/cm2 micro- 
and nanoparticles of different 
composition. Asterisks 
(*,**,***) indicate significantly 
higher levels compared to 
control and corresponds to p 
<0.05, 0.01 and 0.001. For more 
details see paper II. 
 
 
 
In the study by Grassian et al. 198, agglomeration was additionally suggested to be the 
reason to why the larger nanoparticles caused more toxicity than the smaller. Data 
from DLS showed that there were smaller agglomerates for the 21 nm particles than 
for the 5 nm nanoparticles. The interaction of the larger particles were weaker and 
hence allowed the 21 nm particle agglomerates to de-agglomerate and go into the 
deeper parts of the lung, as opposed to the more tightly packed larger agglomerates 
formed by the smaller 5 nm particles, which may be cleared more easily. 
 
A conclusion so far from the results in the present thesis is that particle size does 
not always seem to be a dominant factor driving toxicity. However, particle size is 
highly important in the context of particle deposition in the lung as seen in Figure 4 
illustrating the fact that particles often are in the nanometre size when deposited deep in 
the respiratory tract. Caution must, however, be taken since the size of the individual 
particle may, due to agglomeration, not be the actual size of the particle that is inhaled. 
As previously discussed, immunological response in the lung may also differ for 
nanoparticles and micrometre sized particles, enabling nanoparticles to escape the 
immune defence. In addition, their ability to translocate into cells and possibly further 
into the body might cause a hazard from nanoparticles but not from larger particles. 
The size seems to matter in terms of “availability” but does not seem to be important 
for toxicity per se for all materials.   
 
Recent studies within nanotoxicology have drawn attention to the fact that the surface 
area of particles might be an important factor for toxicity. For example, studies of 
carbon black have suggested that the surface area is the most important determinant of 
effects for particles in nanometre size 111. In study II where the importance of particle 
size was evaluated, only the dose metric mass/surface of cell layer (or mass/volume) 
was used and the results indicated higher toxicity, in particular for CuO particles in the 
nanometre size. In Figure 17, this difference in toxicity is illustrated by the 
mitochondrial depolarisation induced by CuO. However, if these results instead are are 
based on the surface area of the particles (based on BET) the results indicate the 
opposite, i.e. that particles in micrometre size are more toxic than the nanoparticles (see 
Figure 18). The larger particles sediment on to the cells more rapidly and this may be 
part of the explanation for the higher effects observed when dose is expressed as 
surface area. Another explanation might be that the nanoparticles agglomerate in 
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biological media, and consequently the true surface area of the nanoparticles that the 
cells are exposed to might be lower than the measured BET area. 
 
 
Figure 17. Mitochondrial depolarisation in A549 cells from exposure of CuO micro- and 
nanoparticle. Here the dose metric mass/surface of cell layer has been used, indicating a higher 
toxicity for nanoparticles. For more details see paper II. 
 
 
Figure 18. Mitochondrial depolarisation in A549 cells from exposure of CuO micro- and 
nanoparticles. Here the results from Figure 17 have been recalculated for the dose metric 
particle surface/cell surface. The results shows that the nanoparticles have a much larger 
surface than the micrometre particles in the doses presented in Figure 17. If the toxicity of the 
micrometre particles would follow the trend of toxicity seen in this graph (Figure 18), the 
opposite to Figure 17, i.e. a higher toxicity for micrometre particles than for nanoparticles, 
would then be the result if expressed as toxicity/particle surface area instead of toxicity/mass 
dose. 
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It is often highlighted that surface area is a better dose metric than particle mass or 
particle number 10,199. However cautions need to be taken to other aspects of the choice 
of dose metric, such as the importance of size for the deposition of the particles in the 
lungs (as previously discussed). Additionally, particle levels are still measured in 
metrics based on mass for ambient and occupational air. However, OECD recommend 
that exposure levels of materials in nanometre size should be expressed as surface area 
or particle number concentration 200. So a combined use of several dose metrics (mass, 
particle number and surface area) would be preferable.  
 
A large surface area can, however, not be dedicated the whole responsibility for 
toxicity of nanoparticles. If the surface is not reactive, the size of it should not matter. 
The surface reactivity changes when different functional groups or coatings are 
present on the particles. This has been shown by Warheit et al. 201, who compared 
particles of TiO2 in inhalation and instillation experiments and found that only 
nanoparticles with alumina and amorphous silica coatings caused adverse effects. The 
combination of a large surface area and high reactivity might possess a “double 
hazard”, which has e.g. been discussed in terms of inflammatory potential of particles 
202. However, the opposite was seen in study IV of this thesis. The microparticles of 
Cr2O3 were shown to have the largest surface area of all the iron and chromium based 
particles tested in this study. They also caused increased levels of haemolysis of red 
blood cell, indicating a reactive surface, but in terms of toxicity, DNA damage and cell 
viability were not increased (see paper IV). The reason for this might be that Cr2O3 
induces other mechanisms of toxicity not tested in this study, or that proteins of the cell 
medium covered these particles, creating a corona, which will be discussed in the next 
section. 
 
In conclusion, the results in this thesis in combination with results presented by 
others suggest that surface area is one important factor for the determination of 
toxicity - if the surface is reactive. However, for some particles additional factors 
might be of even greater importance. Particle charge, protein corona and ion release 
will be discussed in the next section. 
 
Particle charge, protein corona and ion release 
The nanoparticles of CuO, NiO and Co3O4 investigated in studies I-III, were all 
measured to have high positive zeta potentials and show increased toxicity for many of 
the parameters tested in these studies. One explanation to this can be that cell 
membranes attract positively charged particles due to their negatively charged 
phospholipids located in the inner cell membrane 203. There have been indications that 
positively charged nanoparticles cause cytotoxicity to a higher degree than negatively 
charged particles when evaluated in vitro 204,205. In accordance with this the 
microparticle Cr2O3 evaluated in study IV has a positive zeta potential (in NaCl) 206 and 
was the only particle causing haemolysis of red blood cells (see paper IV). However, 
some nanoparticles with negative zeta potential were also shown to increase toxicity in 
some of the tests in studies I-III. It should also be noted that the zeta potential in these 
studies were measured in water containing 10 mM NaCl. In serum rich cell media, 
metal oxides, with various zeta potential in water, tend to show a slightly negative zeta 
potential 207. This is due to the proteins that are attracted to the surface, creating a layer 
around the particle, a layer often referred to as a protein corona 208. The protein corona 
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might actually be the determinant of what will initially happen to a particle in a 
biological system. The corona may in some cases consist of proteins that are attractive 
for cell interaction, while in other circumstances that will not be the case 209. In a study 
by Cho et al. 117 coating of nanoparticles with serum proteins were shown to reduce the 
particles’ ability to cause haemolysis, showing that the surface charge and reactivity 
was changed by the protective corona. In the present thesis, cells were exposed to 
particles in media containing serum. Consequently the particles are likely to have a 
corona. This has been observed to be highly important, reducing the toxicity of some 
particles such as SiO2 210, while the toxicity of some particles, such as Cu nanoparticles, 
is not affected by the corona to the same extent 211. The corona can have an impact on 
the uptake of particles and e.g. facilitate the uptake by macrophages 212. Upon 
phagocytosis, particles become localised into so called phagosomes, which fuse with 
lysosomes 213 to form acidic phagolysosomes 214. Enzymes in the lysosomal 
environment digest proteins of the corona revealing the reactive surface of the particle 
215. If the particle is positively charged it may interact with the negatively charged 
internal of the lysosomal membrane leading to its disruption. Conclusively, the zeta 
potential of particles might be important inside the lysosomes and for a subsequent 
toxicity. For nanoparticles that easily dissolve, the acidic environment of the lysosome 
may accelerate the dissolution rate of the particles, leading to release of soluble ions 
and, if the ions are toxic, they might disrupt the lysosomal membrane as well. Both 
these mechanisms may lead to release of the particles or ions into the cell, which 
subsequently can trigger inflammation. Cho et al. 117 suggested this mechanism for 15 
metal/metal oxide nanoparticles, which were investigated regarding their potential to 
induce lung inflammation in rats. The study showed that positive zeta potential for 
particles with low solubility, as well as ion release for particles with high solubility in 
acidic environment, was correlated to the degree of acute inflammation in rats.  
 
In study IV, toxicity of micrometre sized iron and chromium based particles were 
studied following exposure of A549 cells. The particles were the alloys FeCr, FeSiCr, 
stainless steel 316L, the metals Fe and Cr, and the oxide Cr2O3, all in a size below 4.1 
μm with the exception of Cr, which was < 39 μm (measured in PBS). In this study, ion 
release was thoroughly investigated for these particles (see paper IV) as well as for 
particles of larger sizes in artificial lysosomal fluid (ALF), which mimics intracellular 
conditions in lysosomes. ALF has a pH of 4.5 and is strongly complexing, due to citric 
acid 216. In ALF, it was observed that the overall release of chromium and iron ions was 
low for the alloys and chromium metals, which was due to a protective chromium-rich 
surface oxide. However, the amount of ions that were released per surface area (metal 
release rate) in ALF increased with decreased particle size for the alloys, but not for the 
pure metals for which it instead decreased. One reason for this might be that the surface 
oxide of the smaller particles more easily is complexed and subsequently dissolved 
than the larger particles in ALF. The importance of pH for release of ions from stainless 
steel 316L particles was further investigated in other more neutral or weakly alkaline 
fluids: Gamble´s solution (GMB) simulating the fluid of the lung lining, artificial sweat 
(ASW) and artificial tear fluid (ATF). The ion release seen in ALF was significantly 
lower in the other fluids. From this follows that ion release from inhaled particles might 
change in an acidic and complexing environment. In study IV, stainless steel caused 
DNA damage in the exposed cells and the reason for this was suggested to be due to 
direct particle-cell interactions since the release of the DNA damaging ions chromium 
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and nickel was low. However, later studies by Hedberg et al. 217 have shown that 
manganese is released from the stainless steel particles. Manganese in the form of 
Mn3O4 nanoparticles have been shown to induce relatively high levels of intracellular 
ROS levels in exposed cells in vitro 177. In study III of this thesis, microparticles of 
MnO2 showed increased levels of DNA damage in both A549 and BEAS-2B cells (see 
paper III). Whether the DNA damaging effect of stainless steel has any significance in 
humans is hard to predict. However, studies of changes at the genomic level in terms 
of histone modifications have been studied in blood leukocytes of steel workers 218. 
The exposure of nickel and arsenic, but not manganese, in the air of the work 
environment was in this study linked to increased levels of the modifications, which 
may in the long run affect gene expression and contribute to cancer.  
 
In study I of this thesis, exposure of CuO nanoparticles was shown to induce much 
higher toxicity in terms of cell death in A549 than Cu ions (from CuCl2) (see paper I). 
This is probably due to the protective cell membrane, which is an excellent barrier 
against most ions. Cronholm et al. 195 showed that the same CuO nanoparticles as 
investigated in this thesis were localised inside A549 cells 4 h after exposure, while no 
CuO nanoparticles could be detected after 24 h, indicating that the CuO nanoparticles 
had dissolved by then. Hence, CuO nanoparticles seem to act like a “Trojan horse” 
bringing in the Cu ions into the cells. The fact that nanoparticles might transport toxic 
ions into the cell is a discussed concept also by others 207. However, it is important to 
consider that the released ions need to have a certain toxic potential to cause damage, as 
was also stated in the study by Cho et al 117 previously discussed. Even though it was 
not studied in the present thesis, an intracellular release of Ni ions is likely an important 
explanation to the high toxicity of NiO 219 observed in study III.  
 
In conclusion, the results within the present thesis suggest that the high toxicity of 
CuO is not due to Cu-ion released in the media. Instead, one likely explanation is 
that CuO nanoparticles might act like a Trojan horse, transporting toxic ions in to 
the cells where released Cu ions (and the reactive particle surface) cause oxidative 
stress. The results also indicate that the intracellular environment can change the 
ion release properties as noted from microsized stainless steel particles that 
released more ions at acidic and complexing conditions. 
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4.3 INTERACTION WITH TOXICITY TESTING AND OTHER 
METHODOLOGICAL CONSIDERATIONS FOR THE COMET ASSAY 
In study III of this thesis, the comet assay, used for analysis of DNA damage and 
oxidative damage of DNA, was evaluated regarding possible particle interaction. The 
comet assay is increasingly used within nanotoxicology. However possible 
interference of particles has only been mentioned briefly in a few published studies 
and interference with the restriction enzyme FPG has, as far as I am aware, not been 
considered at all prior to study III of this thesis.  
 
 
4.3.1 Interference of particles with the comet assay 
In study III, the comet assay was initially evaluated with cells exposed to the 
chemical photosensitiser Ro, which, when in combination with light, induces 
oxidative damage to DNA (mostly in the form of 8-oxoguanine). When using FPG 
the results clearly indicated that the assay found the induced damage and it supported 
the general understanding that the comet assay is reliable to use for chemicals. 
Human lung cell lines (A549 and BEAS-2B) exposed to a wide range of metal 
containing particles both as micro- and nanoparticles showed that several of the 
particles induced DNA breaks but only low levels of oxidative damage to DNA (see 
paper III). This had also been a phenomenon seen in study I and II. These results can 
of course be due to low oxidative potential of the particles, but interaction within the 
method is also a possibility. In study III, the oxidative capacity of several of the 
particles was, however, shown by their ability to generate intracellular ROS. In 
addition Ag nanoparticles and subway particles also caused oxidation of the DNA 
base guanine when exposed non-cellularly and evaluated by HPLC.  
 
The hypothesis that particles may interact with FPG used within the comet assay 
arises from the fact that particles have been observed in the comet nucleoid after 
particle exposure 220,221. Most likely, the particles get in contact with the nucleoid 
during the comet assay, as discussed in a study by Karlsson 160. The presence of 
particles close to DNA during the comet assay procedure consequently makes 
interaction with FPG a possible scenario. In study III, incubation of FPG with the 
particles, at an approximate intracellular dose, led to lower FPG activity, particularly 
for the nanoparticles of Ag, but also with CeO2, Co3O4 and SiO2 (see Figure 19). 
Further investigations of these particles revealed that the decreased activity of FPG 
from Ag incubation mainly was due to released Ag ions. For CeO2 and Co3O4, the 
decreased activity was due to the particles, and for SiO2 FPG seemed to be active 
although bound to the particles (see section 3.3.10 for procedure and paper III for 
more details).  
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Figure 19. Detection of oxidatively damaged DNA (FPG sites) in Ro exposed A549 cells by 
the comet assay, using FPG incubated with particles in an estimated intracellular dose. The 
dotted line represent the normal capacity of FPG to find the oxidativley damaged DNA.  
 
 
The mechanism by which particles or ions inactivate FPG may be through 
conformational changes of the enzyme or interference with the structure of the 
enzyme, which is important for the substrate specificity. FPG is a zinc finger protein 
and it is the ‘‘finger-like’’ structure that wraps around DNA and enables the binding 
of the enzyme to DNA during repair of oxidatively damaged DNA. It has been shown 
that the active site of the finger structure is positively charged 222 with one Zn atom 
223 anchored between four SH groups 224. This makes the active site a possible target 
of metal ions, which might take the place of the Zn atom. Low doses of metal ions of 
Cd(II), Cu(II) and Hg(II) have been observed to have a high affinity for the zinc 
finger of FPG, causing pronounced enzymatical inhibition 225. In study III, Ag ions 
caused FPG to totally lose its ability to detect oxidatively damaged DNA in the comet 
assay. This disturbance is most likely due to the binding of Ag ions to the SH groups 
at the active site of the enzyme. Binding of Ag ions to SH groups in proteins is 
suggested to be the mechanism behind the well-known antibacterial effect of Ag 226.  
 
After the publication of this study another study also addressed this issue, with the 
focus on interaction of SiO2 nanoparticles 227. The procedure for testing this was quite 
different compared to the study in the present thesis. HeLa cells were exposed to SiO2 
nanoparticles before the induction of oxidative DNA damage by the photosensitiser 
Ro. The comet assay was then performed with FPG and the same amount of damage 
with and without the pre-exposure of SiO2 was detected. This can be compared to 
study III where the cells are only exposed to the photosensitiser and not to the 
particles. Instead, the enzyme was incubated with particles and ions separately (see 
paper III). The authors, Magdolenova et al. conclude that their results indicate that the 
nanoparticles did not interfere with FPG. However, whether the highly reactive 
photosensitiser Ro react with SiO2 nanoparticles before the comet assay was 
performed, was not stated to be tested. An interaction between the photosensitiser and 
SiO2 might cause structural or chemical changes of the particle or ions. What form of 
the particle that is actually present in the nucleoid, if present at all, when using this 
study design is in fact difficult to know.  
  Ag           CeO2            Co3O4       Fe3O4         NiO           SiO2 
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The results in the studies (I, II and III) within this thesis suggest that oxidative 
stress caused by nanoparticles may, for some nanoparticles, be underestimated if 
the comet assay with FPG is used for analysis of oxidatively damaged DNA. 
Thus, this method may not be the most suitable to use for measurements of 
oxidatively damaged DNA from particles after exposure to cell lines. This study 
highlights that established, reliable genotoxicity tests for chemicals may not 
always be suitable for studying genotoxicity of particles. 
 
 
4.3.2 Comparison of FPG and hOOG1 for detection of oxidative DNA damage 
It has been suggested by Smith et al. 162 that hOGG1 finds 8-oxoguanine more 
specifically than FPG. The authors compared the ability of FPG and hOGG1 to find 
oxidatively damaged DNA in the form of 8-oxoguanine, but other damages such as 
alkylation were also evaluated. It was observed that hOGG1 found less damage and 
was therefore suggested to be more specific. However, the incubation time for the 
enzymes differed (10 min for hOGG1 and 30 min for FPG), and it can therefore not be 
excluded that experimental differences explain the level of damage detected. To 
investigate this further, within the concept of this thesis, A549 cells were exposed to 0.4 
μM Ro and light irradiation. Enzyme incubations for 5, 10, 20, 30, 45 and 60 min were 
applied and the enzyme dilution was set to 1:1000 (0.048 U/gel) in enzyme buffer (the 
same as in the study by Smith et al.). The results can be seen in Figure 20 and indicate 
that it is not until the incubation time of 30 min is reached that the damage levels seem 
to flatten out. These results indicate that an incubation of 10 min is not enough for 
hOGG1 to find all damage present in the cells.  
 
 
 
Figure 20. Evaluation of different incubation times for hOGG1 in the comet assay. The A549 
cells used for the evaluation were exposed to 0.4 μM photosensitiser Ro and light. The 
incubated with hOGG1 ranged from 5-60 min and the enzyme hade a concentration of 0.048 
U/gel (diluted 1:1000). The box indicates a possible plateau. Each point represents three 
independent experiments ± SD. 
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In further studies, the optimal concentration of hOGG1 was evaluated as well. The 
results showed that hOGG1 has not reached a stable plateau in the dilution 1:1000 and 
that a dilution of 1:2000-1:5000 probably would give a more correct result, since the 
higher concentration might cause unspecific “cutting” by the enzyme. When oxidative 
damage in A549 and BEAS-2B cells was evaluated using the comet assay after 
exposure to the photosensitiser Ro in a concentration range (0-0.6 μM) and using a 30 
min incubation of hOGG1 diluted 1:4000 times the same result as in the study by Smith 
et al. was obtained (see Figure 21); namely, a lower level of damage detected by 
hOGG1. The shorter exposure time in the study by Smith et al. was most likely 
compensated by the higher concentration of hOGG1. In conclusion, the result of the 
present study is in line with the study by Smith et al. However, the experimental 
conditions could have been optimised further, in the study by Smith et al.  
 
 
 
 
Figure 21. Oxidative DNA lesions from photosensitiser Ro in cultured A549 and BEAS-2B cells 
evaluated with FPG and hOGG1 using the comet assay after exposure to 0 - 0.6 μM Ro and 
light. Each point represent the average of four independent experiment ± SD. All the lines for 
A549 and BEAS-2B have R2 values of 0.99 - 1.00.  Stars (***) indicate the statistical significant 
difference of p < 0.001, estimated by two-way-ANOVA, when the detection capacity of the two 
enzymes is compared. There is no significant difference between the cell lines when evaluated 
with the same enzyme. 
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4.4 HUMAN EXPOSURE TO SUBWAY PARTICLES AND HEALTH 
EFFECTS 
A project was conducted during the years of 2006-2010 attempting to fill the existing 
knowledge gap regarding health effects in humans after exposure to air at a subway 
station. This project consisted of three studies, by which the study present in this thesis 
(study V) is the last one. All studies were conducted at a subway station in Stockholm 
(Odenplan) and the air was measured to be rich of metal containing particles. The study 
design for the three studies was the same, but with somewhat different end points, study 
subjects and time frames of evaluation (see paper V for details of the third study).  
 
The two first studies investigated the acute inflammatory responses in healthy and 
mildly asthmatic human subjects respectively, 14 h after a 2 h long exposure at the 
subway station. In healthy individuals, a small increase in fibrinogen and regulatory T-
cells expression was detected in blood after the exposure, indicating a systemic 
biological response 65. This was, however, not seen for the mild asthmatics, whom 
instead showed an increase in T-cells expressing the activation marker CD25 in BAL, 
indicating a local effect in the lungs 142. A conclusion from these studies is that an 
immunological reaction occurs from the exposure, and that the mild acute responses 
differ for asthmatics and healthy individuals.  
 
To further investigate the immunological effects in healthy individuals the study 
present in this thesis (study V) was conducted including repeated measurements during 
a longer follow up time (24 h). Since blood is a much more suitable method for 
repeated measurements than BAL, and since effects was previously observed in blood 
of the healthy human subjects, blood sampling was used for this study. The blood 
samples were used to investigate effects on lung permeability and inflammation 
responses, in terms of immune cell differentiation, characterisation of lymphocyte 
subsets as well as fibrinogen levels. In addition, the DNA damaging effect and 
oxidative stress seen in previous in vitro studies from the research group 68,69, as well as 
DNA repair was investigated in human PBMC. The parameters were investigated after 
a 2 h exposure at the subway station and compared to the same exposure in a clean 
environment.     
 
A total of 18 subjects were evaluated and in short the results indicated a direct 
inflammatory response, as a decrease in cell concentration of lymphocytes in blood 
after the subway exposure. In the end of the follow-up time discreet indications of 
inflammatory responses in blood were also detected, as changes in the lymphocyte 
subpopulation. More precisely, NK-T and T-regulatory cells were increased, and T-
helper cells and the ratio of CD4/CD8 cells were decreased. DNA damage in PBMC of 
some of the study subjects was increased 23 h after exposure, indicating certain 
sensitive subjects within the study group.  
 
The increased expression of regulatory T-cells, the tendency of increased NK-T cells 
and the small increase in T-helper cells in blood of healthy subjects 14 h after subway 
exposure, seen in the first study could not be detected in the present study 24 h post 
exposure when subway and control exposure was compared. However, the present 
study design allowed for a comparison within the same day i.e. before exposure versus 
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24 h after the exposure, ruling out the influence from possible changes in basic health 
status of the subject between the two different exposure occasions (there was a 
minimum of 3 weeks between the control and subway exposure). This comparison 
showed, in consistency with the first study, a significant increase of the regulatory T-
cells and NK-T cells 24 h after subway exposure. No such difference was seen for the 
control exposure. The significant drop in the CD4/CD8 ratio in the present study was 
not detected after 14 h in the first study. The levels of this ratio are, however, within a 
normal range and the drop in CD4/CD8 ratio is a reflection of the drop in T-helper 
cells, and indicate that the immune system has reacted. In the second study where 
mildly asthmatics were exposed in precisely the same manner as the healthy subjects in 
the first study, no effect at all was detected in blood. In the first and second studies 
lymphocyte subsets were also measured in BAL fluid from lung. In the healthy 
subjects, no effects were detected, but the asthmatics showed an increase in T-helper 
cells expressing CD25 (CD4+/CD25 cells). The conclusions from the two first studies 
were that asthmatics seemed to get a local effect in the lungs whereas the healthy 
subjects had a systemic reaction in the blood. Changes in lymphocyte subsets, such as 
the decrease of T-helper cells and the increase of regulatory T-cells and NK-T cells in 
the present study of this thesis, may be seen before an inflammation has been 
established and other inflammation markers are present.   
 
The decreased concentration and differential (%) of lymphocytes measured in 
peripheral blood in the present study (study V), directly after the subway exposure, 
indicates a direct effect of the subway exposure, most likely in the lungs. The level 
returned to normal within two hours, and the leucocytes, neutrophils, eosinophils, 
basophils and monocytes were not affected. All together, this points towards a non-
extensive reaction at this time-point. This decrease of immunological cells in blood can 
be a result of cell migration out of blood into an inflammation site. Hence, in scope of 
this study the decrease of lymphocytes in blood after subway exposure might be an 
indication of an induced inflammation in the lung.  
 
In a study by Bigert et al. 71, the inflammatory markers PAI-1, IL-6 and fibrinogen 
showed a tendency to be increased in platform workers of the subway. Modest elevated 
levels of fibrinogen were also observed in the first study of healthy subjects, 14 h after 
the subway exposure. However, there was no increase in fibrinogen in the present study 
after 24 h. So the effect seen after 14 h seems to have declined 24 h after the exposure 
occasion. 
 
The self reported symptoms that each subject stated during the study indicated a very 
small increase in perceived irritation in the eyes and nose during the subway exposure, 
compared to the control exposure. The experience of disturbing smell was low but 
showed the most prominent increase when ranked, as 2 (i.e. a small disturbance) in the 
0-10 scale, compared to the control environment where all parameters were ranked as 0 
(i.e. no disturbance). In the first study of healthy volunteers, the self reported 
experienced irritation from the lower airway was increased, which is in contrast to the 
lack of symptoms in the present study. Self reported measurements constitute a 
somewhat unspecific tool and since it is not possible to blind this part of the study, 
these results may be influenced by the fact that the participants are aware that they are 
in the subway. However, other measured health effects and the correlation of these to 
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self reported symptoms could be of interest, e.g. the correlation between PEF lung 
function test and perceived irritation from the lower airways. There was, however, no 
effects seen in PEF for the subway exposure, neither in the self reported symptoms of 
irritation of the lower airways.  
 
The air monitoring of the subway station Odenplan, including particle number, PM2.5, 
PM10, NO and NO2, were in the same level for all studies. However, the particle 
levels, measured as PM2.5 and PM10, were 3.5 and 2.0 times lower than at the 
Mariatorget station in Stockholm, as previously measured by Johansson and Johansson 
63. There may be several reasons for this, such as differences in the air flow and air 
conditioning at the stations, the architecture of the platform and number of passing 
trains. It may also be so that the new version of subway trains (C20 trains), which are 
used at the lane passing Odenplan cause less emission of particles compared to the 
older trains (CX trains) that passed Mariatorget station at the time of those 
measurements. Furthermore, it has been suggested that diesel particles from the street 
level may be present at subway stations 67. However, the personal exposure to NO2 in 
the present study, reflecting exposure to traffic pollution, did not indicate any extra 
exposure of traffic pollution for the exposure session in the subway when compared to 
the control exposure session. 
 
Previous studies have shown DNA damage in A549 cells after exposure to subway 
particles in vitro. This was also seen in study III of this thesis, in both A549 and BEAS-
2B cells. In study III, intracellular ROS in A549 cells and oxidation of the DNA base 
guanine was also shown after exposure of subway particles (see paper III). However, in 
the present human study a broader aspect of the toxicity was evaluated, since these 
damages were measured in cells of blood from exposed humans. An initiation of 
inflammation in the lungs includes release of cytokines and activation of cells of the 
immune system. It constitutes a local reaction in the lungs that may spread to the rest of 
the body and influence production and distribution of different immunological cells. 
Effects of PBMC, which were studied, highlight this systemic inflammatory response, 
and induction of damage to the DNA may be the result of an initiation of an oxidative 
stress response or other mechanisms of the immunological defence. Disturbance of the 
DNA repair system of these cells is also a possibility, and the DNA damage caused by 
direct effects or by the decreased ability of cells to repair damages, are important initial 
events in carcinogenesis. An increase of DNA damage in PBMC was detected 23 h 
post subway exposure for some of the subjects. In these subjects, the DNA damage 
increased by 24% in the PBMC. Since this is the first study of DNA damage in human 
subjects after exposure to air at a subway station, it is not possible to compare these 
results to studies from similar environments. However, studies of humans exposed to 
traffic related ultrafine particles from one of Copenhagen’s busiest streets have shown 
increased levels of DNA damage in PBMC with 41-60% when measured with the 
comet assay, 6 and 24 h after the start of the particle exposure 166. The level of DNA 
damage in PBMC has also been shown to be increased by 50% after high levels of 
benzene and ultrafine particle exposure in the city of Benin 228. The statistical analyses 
in the present study showed that the increase in DNA damage after subway exposure 
was not statistically significant when compared to control exposure. This was due to 
overrepresentation of high levels of DNA damage in the study group that had been 
randomly chosen to start with the control exposure. Five out of seven subjects in this 
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group showed an increase in DNA damage 23 h after the subway exposure compared to 
only two out of eleven subjects in the group starting with the control exposure. The 
analysis did not point towards a drop-over effect from the subway exposure, and 
therefore the results may indicate a certain sensitive subpopulation among the subjects 
studied.  
 
Oxidatively damaged DNA in PBMC is an indicator of systemic oxidative stress 
relevant for e.g. cardiovascular diseases. This parameter was not affected by the 
subway exposure at any of the time points. However, exposure to particles can increase 
the repair of oxidatively damaged DNA, masking the actual damage levels of exposure, 
a phenomenon which has previously been discussed in relation to human exposure of 
wood combustion PM 228. To be able to draw conclusions about oxidative stress 
induced DNA damage and to really understand what the actual effect of the exposure 
is, it is important to investigate the repair capacity as well. The repair capacity of 
PBMC was, however, unchanged in the present study (study V).  
 
The combination of small health effects in exposure studies and relatively small groups 
of subjects makes it hard to conclude if effects measured are of statistical significance 
or not. The number of study subjects in the present study was based on previous studies 
and power calculations performed in studies of health effects from exposure in a road-
tunnel environment with high concentrations of particles. The size and composition of 
particles differ greatly between exposure in road and subway tunnels, therefore it is not 
surprising if different effects are observed. A larger number of study subjects would 
have been needed to establish a possible significance for some of the effects detected in 
the subway, particularly in the case of DNA damage.  
 
In conclusion, this human study of exposure to metal containing particles at a 
subway station indicates discrete signs of an induced inflammation. A decrease in 
cell concentration and differential (%) of lymphocytes in blood was seen immediately 
after the subway exposure. Some changes in the lymphocyte subpopulation were seen 
24 h post exposure along with a slight increase in DNA strand breaks in PBMC for 
some of the exposed subjects. Whether the small effects observed impose any real 
health risk is difficult to predict. Nevertheless, the evidence does not indicate that a 
short subway exposure cause any major acute inflammatory health effects in healthy 
humans.  
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5 SUMMARY AND CONCLUSIONS 
 
The main aim of this thesis was to increase the knowledge concerning toxicity and 
underlying biological mechanisms from exposure of metal containing particles through 
inhalation. In the studies conducted, this was investigated in vitro in lung cells after 
exposure to engineered micro- and nanoparticles, as well as after exposure to particles 
from steel industries and the subway system. Additionally, as an example of exposure 
to metal containing particles, health effects from subway particle exposure was 
investigated in a human study where healthy humans were exposed to the air at a 
subway station in Stockholm, Sweden. 
 
The main indicators for toxicity and health effects investigated were markers for 
oxidative stress and DNA damage. In the human study, inflammation was also 
investigated. The comet assay was used in all studies for the measurement of DNA 
damage, oxidatively damaged DNA and DNA repair. Consequently, methodological 
considerations regarding the comet assay were an important part of this thesis.  
 
 
5.1 CONCLUDING REMARKS 
Here follows some specific conclusions that can be draw from the presented studies 
(studies I-V):  
 
• The chemical composition of the metal containing particles seems to be crucial 
for the toxicity tested. CuO and NiO nanoparticles particularly stood out, 
inducing high toxicity towards lung cells. One likely explanation for this is that 
these nanoparticles might act like Trojan horses, transporting toxic ions into the 
cells, causing oxidative stress.  
 
• The pH and complexing agent of the intracellular environment can change the 
ion release properties of particles, as was seen for the stainless steel 316L 
microparticles that released more ions at acidic and complexing conditions.  
 
• The combination of surface composition (surface oxide) and particle size of 
iron and chromium based microparticles seem to be linked to the amount of 
released ions in a acidic and complexing fluid.  
 
• The size of the particles is important for the toxicity of CuO (when dose is 
expressed as mass), which was seen as higher toxicity for nanoparticles than for 
micrometre particles of CuO. However, particle size does not always seem to be 
a dominant factor driving toxicity per se, indicated by the investigation of other 
metal containing particles in the present thesis. The literature shows, however, 
that in the context of particle deposition, the immunological response towards 
the particles in the lung and the ability of particles to translocate, the size still 
might play an important role.  
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• The surface area is suggested to be an essential dose metric to consider for the 
toxicity of nanoparticles, particularly if the surface is reactive.  
 
• Some nanoparticles indicate interaction with FPG used within the comet 
assay. Oxidative DNA damage may consequently be underestimated, and the 
comet assay with added FPG may not be suitable for detecting oxidatively 
damaged DNA in cell lines after particle exposure.  
 
• The fact that Ag nanoparticles interfered with FPG, implies that Ag 
nanoparticles might affect the repair of DNA damage in cells. Consequently, 
this suggests a relatively new mechanism for the toxicity of nanoparticles. 
 
• The human exposure to air rich in metal containing particles at a subway station 
caused discrete signs of inflammation: a decrease in lymphocytes in blood 
immediately after the exposure, some changes in the lymphocyte subpopulation 
24 hours post exposure along with a slight increase in DNA strand breaks in 
PBMC for some of the exposed subjects. Whether these small effects observed 
impose any real health risk is difficult to predict. Nevertheless, the evidence 
indicates that a short subway exposure does not cause any major acute 
inflammatory health effects.  
 
 
To be able to understand the toxicity of metal containing micro- and nanoparticles, this 
thesis attempted to arrive at some kind of conclusion concerning which particle 
characteristics that mainly drive the toxicity. However, the characteristics varied greatly 
for the investigated particles and the combination of the different physicochemical 
properties (chemical composition, size, solubility, surface reactivity etc.) made this 
kind of conclusion very complex to perform. In addition, there might be characteristics 
of particles that are yet to be revealed to be important, but that are not even considered 
or discussed today due to lack of knowledge.  
 
Regarding nanoparticles, this thesis is in line with the growing consensus that 
nanoparticles are not a toxicologically uniform class of materials and therefore they 
should not be viewed upon as a homogenous group with simple toxic attributes. There 
is not one specific property of nanoparticles that can be held responsible for the 
toxicity. Knowing this, researchers have suggested again and again that nanomaterials 
should be tested individually (we suggested it in the first studies of this thesis as well). 
However, lately a healthy debate regarding this has arisen. Since it is not possible to 
evaluate all different nanoparticles one by one, that would be extremely time 
consuming and expensive, and possibly not even operable. The call for individual 
evaluation of nanoparticles previously made is most likely a call for bringing awareness 
to the differences that exist between different nanoparticles, in terms of their 
characteristics and toxicity. Today, there is a need for agreement and development of 
reliable standardised test methods and toxicity end points relevant for human health so 
we can start screening the nanoparticles that are out there, already on the market. It 
might feel impossible to agree upon this. However, there is no other options, we cannot 
test all nanoparticles individually. Some materials and characteristics show to be linked 
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to toxicity more often than others and these are probably particles and characteristics 
that we should be particularly cautious with. 
 
 
5.2 FUTURE REMARKS 
Nanomaterials, including nanoparticles, may open tremendous opportunities for 
different applications in the fields of, for example, medicine, engineering, electronics, 
optics, consumer products, alternative energy and water cleaning. However, too little is 
known about their capability to cause adverse effects in humans and the ecosystem. 
The lack of toxicology data on engineered nanoparticles is a problem causing 
inadequate risk assessment, and is something that needs more attention and more 
studies, not in the distant future, but today! 
 
I personally find it exciting to think about all the tremendous applications that 
nanotechnology might bring in the future. At the same time, when thinking of the 
enormous amount of nanomaterials used today in the society and the potential 
exposures this brings, it can scare me. We are using these materials in so many contexts 
in our society today without knowing if they will make us unwell in the future! What 
will happen if we discover that some of them are toxic to us and/or the environment? 
We are in urgent need for some action!  
 
In relation to the industrially relevant particles and particles present in the subway, 
which were investigated in this thesis, I believe that more in-depth investigations of 
exposure are required. Studies on effects of long term exposure, occupational exposure 
of humans as well as exposure to sensitive groups are needed. 
 
The future in the field of particle toxicology is exciting and slightly frightening at the 
same time, particularly regarding nanoparticles. I presume we should listen to Marie 
Currie, who is cited on the first page of this thesis: we can not let us be scared and give 
up in our endeavour to find the answers to our questions! 
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6 SVENSK POPULÄRVETENSKAPLIG 
SAMMANFATTNING 
Partiklar i stadsmiljö, från bilavgaser och uppriven asfalt (från dubbdäcksanvändning), 
har länge förknippats med olika typer av hälsoproblem och sjukdomar, såsom 
försämring av astma och kronisk obstruktiv lungsjukdom (KOL) samt cancer och hjärt-
kärlsjukdomar. Även partiklar i olika dammiga arbetsmiljöer och industrier, särskilt 
partiklar av metaller som bildas vid svetsning, är kopplade till flera negativa 
hälsoeffekter. Under senare år har det framkommit att människor även blir exponerade 
för partiklar som innehåller metaller när de vistas i tunnelbanesystem, men om det 
innebär någon risk för hälsan är inte känt.  
 
Idag används allt oftare mycket små metallinnehållande partiklar, så kallade 
nanopartiklar, exempelvis i olika konsumentprodukter. Det finns nanopartiklar i 
solkräm, målarfärg, byggmaterial, elektriska apparater, tyger, kläder och kosmetika 
m.m. Nanopartiklar besitter en rad specifika kemiska egenskaper till följd av sin 
storlek, vilka kan komma till stor nytta i olika sammanhang. Den breda användningen 
betyder att exponering för metallhaltiga partiklar med stor sannolikhet sker i samhället 
idag och att det troligtvis kan komma att öka i framtiden till följd av den ökade 
användningen i olika produkter. 
 
Det finns i dag ett stort behov av mer kunskap om huruvida metallinnehållande 
partiklar kan påverka vår hälsa negativt. Det främsta syftet med studierna som 
presenteras i den här avhandlingen var att undersöka giftigheten hos en rad partiklar 
och försöka förstå på vilket sätt eventuella skador uppstår i celler efter exponering för 
partiklarna. Detta undersöktes med hjälp av odlade, mänskliga lungceller i studierna I-
IV (artiklarna I-IV) och i studie V undersöktes effekten hos försökspersoner som fått 
andas in luft innehållande partiklar på en tunnelbanestation. 
 
I studierna I-IV undersöktes giftigheten och de bakomliggande skademekanismerna för 
ett brett spektrum av metallinnehållande partiklar, från mycket små nanopartiklar till 
lite större partiklar (”mikropartiklar”). I dessa fyra studier undersöktes framförallt hur 
materialsammansättningen, d.v.s. vilken metall/metaller partiklarna består av, påverkar 
deras nivå av giftighet. Även betydelsen av partiklars storlek och om de friger joner 
(d.v.s. löses upp) studerades. De effekter som mättes hos lungcellerna efter 
partikelexponering var: celldöd, skador på arvsmassan (DNA), förekomsten av skadliga 
radikaler i cellen och skador på DNA kopplade till detta. Dessutom mättes skador på 
”energifabrikerna” i cellen (mitokondrierna) samt huruvida röda blodkroppar sprack 
efter att de exponerats för partiklarna. Alla dessa skador kan vara viktiga för 
utvecklandet av olika sjukdomar och negativa hälsoeffekter hos människan, exempelvis 
för cancer och inflammation. Resultaten av undersökningarna visade att det fanns en 
hög variation i giftighet hos de undersökta partiklarna. Särskilt skadliga var partiklar av 
koppar (CuO) och de små partiklarna (nanopartiklarna) var betydligt mer skadliga än 
de större partiklarna. En trolig orsak till detta är att kopparpartiklarna löser upp sig och 
avger giftiga joner. En teori är att partikeln, likt en trojansk häst, tar sig in i cellen och 
sedan avger de giftiga jonerna. Dessa kan i sin tur skada cellen. 
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I studie IV undersöktes industriellt relevanta partiklar av järn och krom. Av dessa 
visade sig partiklar av rostfritt stål reagera olika i olika mänskliga vätskor. Resultaten 
avslöjade att mer joner frigavs från dessa partiklar i sura vätskor (surt pH). Giftigheten 
för de järn- och krombaserade partiklarna var relativt låg då odlade lungceller utsattes 
för dessa, men höga nivåer av skador på DNA kunde ses från både partiklar av rostfritt 
stål och från nickelpartiklar (NiO). Även partiklar av krom (Cr2O3) tycktes vara 
skadliga på så sätt att de påverkade röda blodkroppar. 
 
I studie III (artikel III) sågs en ökad förekomst av radikaler i odlade lungceller efter 
exponering för flera metallinnehållande partiklar, men några skador från dessa radikaler 
kunde inte upptäckas på DNA. Genom noggranna eftersökningar visade det sig att detta 
kunde bero på att partiklarna påverkade ett protein (enzym) som är viktigt för 
mätmetoden (den så kallade ”kometmetoden”). Detta var särskilt tydligt för vissa 
partiklar och nanopartiklar av silver påverkade metoden allra mest, vilket visade sig 
bero på att silverjoner frigetts från partiklarna.  
 
I studie V (artikel V) undersöktes effekter hos friska försökspersoner som vistats två 
timmar på en tunnelbanestation (Odenplan i Stockholm). Personerna fick under 24 
timmar lämna blodprover vid särskilda klockslag, samt genomföra tester för att se om 
deras andningsförmåga påverkats av vistelsen på stationen. Resultaten visade att en 
liten inflammatorisk respons i form av en minskad nivå av immunceller i blodet 
uppstod direkt efter vistelsen, men att effekten var snabbt övergående. I slutet av 
uppföljningstiden kunde även små förändringar ses i vilken typ av immunceller som 
fanns närvarande i blodet. En ökning av skador på DNA kunde även ses i celler i blod 
hos några av försökspersonerna i slutet av uppföljningstiden. 
 
Sammanfattningsvis visar resultaten från dessa studier att den kemiska 
sammansättningen av metallinnehållande partiklar är avgörande för giftigheten hos de 
testade partiklarna. Denna avhandling belyser särskilt giftiga effekter av nanopartiklar 
av koppar (CuO) och nickel (NiO). Frisättning av joner från partiklar inuti cellerna kan 
vara en viktig mekanism bakom de skador som ses i celler efter exponering. 
Frisläppandet av joner från partiklar observerades även öka för partiklar av rostfritt stål 
vid surt pH. Dessutom visar studierna i denna avhandling att vissa nanopartiklar kan 
påverka kometmetoden med vilken skador på DNA från radikaler kan mätas. Denna 
upptäckt tydliggöra därför vikten av att noga överväga vilka lämpliga testmetoder man 
väljer för att testa partiklars giftighet. Slutgiltigt visar denna avhandling att en kortvarig 
exponering för luft (rik på metaller) vid en tunnelbanestation ger en liten respons från 
immunförsvaret, men att några större akuta hälsoeffekter på människor inte tycks 
uppstå. 
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